<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001897" GROUP_ID="MENSTR" ID="972499082323553124" MERGED_FROM="" MODIFIED="2009-02-11 23:29:04 +0100" MODIFIED_BY="Jane Clarke" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Short title (no longer in use): Procedures after reproductive surgery&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-02-12 10:43:26 +1300" NOTES_MODIFIED_BY="jane clarke" REVIEW_NO="NJ 471" REVMAN_SUB_VERSION="5.0.17" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2009-02-11 23:29:04 +0100" MODIFIED_BY="Jane Clarke">
<TITLE>Postoperative procedures for improving fertility following pelvic reproductive surgery</TITLE>
<CONTACT MODIFIED="2009-02-11 23:29:04 +0100" MODIFIED_BY="Jane Clarke"><PERSON ID="0A9FF8B382E26AA200DE9984F9827998" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Andrew</FIRST_NAME><LAST_NAME>Watson</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>andy.watson@tgh.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>Tameside &amp; Glossop Acute Services NHS Trust</DEPARTMENT><ORGANISATION>Tameside General Hospital</ORGANISATION><ADDRESS_1>Fountain Street</ADDRESS_1><CITY>Ashton-Under-Lyme</CITY><ZIP>OL6 9RW</ZIP><REGION>Lancashire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 161 3316158</PHONE_1><PHONE_2>+44 1332 75148</PHONE_2><FAX_1>+44 161 331 6074</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-02-11 23:29:04 +0100" MODIFIED_BY="Jane Clarke"><PERSON ID="0256F45882E26AA200CD32E5F73F3F60" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>James</FIRST_NAME><MIDDLE_INITIALS>M N</MIDDLE_INITIALS><LAST_NAME>Duffy</LAST_NAME><POSITION>Foundation Year One Doctor (Academic Surgery)</POSITION><EMAIL_1>jamesmnduffy@hotmail.co.uk</EMAIL_1><ADDRESS><ORGANISATION>Guy's and St Thomas' Hospital</ORGANISATION><ADDRESS_1>Westimister Bridge Road</ADDRESS_1><CITY>London</CITY><ZIP>SE1 7EH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 77980115547</PHONE_1></ADDRESS></PERSON><PERSON ID="9027" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Neil</FIRST_NAME><LAST_NAME>Johnson</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>n.johnson@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics &amp; Gynaecology</DEPARTMENT><ORGANISATION>University of Auckland</ORGANISATION><ADDRESS_1>PO Box 92019</ADDRESS_1><CITY>Auckland</CITY><ZIP>1003</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 3737599 ext: 89488</PHONE_1><FAX_1>+64 9 3035969</FAX_1></ADDRESS></PERSON><PERSON ID="F9B3654982E26AA20025F63939E7A472" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gaity</FIRST_NAME><LAST_NAME>Ahmad</LAST_NAME><POSITION>Registrar</POSITION><EMAIL_1>gaityahmad@hotmail.com</EMAIL_1><EMAIL_2>gaityahmad@aol.com</EMAIL_2><ADDRESS><DEPARTMENT>Obstetric &amp; Gynaecology </DEPARTMENT><ORGANISATION>Stepping Hill Hospital</ORGANISATION><ADDRESS_1>30 Badger Road</ADDRESS_1><ADDRESS_2>Altrincham</ADDRESS_2><CITY>Cheshire</CITY><ZIP>WA14 5UZ</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="0A9FF8B382E26AA200DE9984F9827998" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Andrew</FIRST_NAME><LAST_NAME>Watson</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>andy.watson@tgh.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>Tameside &amp; Glossop Acute Services NHS Trust</DEPARTMENT><ORGANISATION>Tameside General Hospital</ORGANISATION><ADDRESS_1>Fountain Street</ADDRESS_1><CITY>Ashton-Under-Lyme</CITY><ZIP>OL6 9RW</ZIP><REGION>Lancashire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 161 3316158</PHONE_1><PHONE_2>+44 1332 75148</PHONE_2><FAX_1>+44 161 331 6074</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-10-29 11:42:27 +1300" MODIFIED_BY="jane clarke" NOTES="&lt;p&gt;Minor update: 8/23/02&lt;/p&gt;&lt;p&gt;New studies sought but none found: 8/23/02&lt;/p&gt;&lt;p&gt;Reformatted: 8/26/99&lt;/p&gt;" NOTES_MODIFIED="2008-10-29 11:42:27 +1300" NOTES_MODIFIED_BY="jane clarke">
<UP_TO_DATE>
<DATE DAY="22" MONTH="8" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="22" MONTH="8" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="28" MONTH="8" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2000"/>
</DATES>
<WHATS_NEW MODIFIED="2009-02-12 10:43:26 +1300" MODIFIED_BY="jane clarke" NOTES="&lt;p&gt;A new search was performed in August 2007 however no new trials were found for inclusion.  A single trial was excluded from the review as it was quasi-randomised.  Text was updated as required.&lt;/p&gt;" NOTES_MODIFIED="2009-02-12 10:43:26 +1300" NOTES_MODIFIED_BY="jane clarke">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2009-02-12 10:43:26 +1300" MODIFIED_BY="jane clarke">
<DATE DAY="11" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Review updated August 2008</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-02-12 10:41:58 +1300" MODIFIED_BY="jane clarke">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-02-12 10:41:55 +1300" MODIFIED_BY="jane clarke">
<DATE DAY="12" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Search strategy re-run. No new RCTs identified. Text of the review updated especially the review methodology, results, discussion and conclusions. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-02-12 10:41:58 +1300" MODIFIED_BY="jane clarke">
<DATE DAY="26" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="31" MONTH="3" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-12 08:56:50 +1300" MODIFIED_BY="jane clarke">
<SUMMARY MODIFIED="2008-10-29 11:33:22 +1300" MODIFIED_BY="jane clarke">
<TITLE MODIFIED="2008-05-27 09:57:46 +1200" MODIFIED_BY="Julie A Brown">Postoperative procedures for improving fertility following pelvic reproductive surgery</TITLE>
<SUMMARY_BODY MODIFIED="2008-10-29 11:33:22 +1300" MODIFIED_BY="jane clarke">
<P>There is insufficient evidence to show the benefit or harm of routine hydrotubation or second-look laparoscopy following surgery on a woman's reproductive system. Surgery to correct tubal damage is undertaken to improve pregnancy and live birth rates. Laparoscopy (where the abdominal organs are examined through a small surgical cut in the abdomen) to treat postoperative adhesions and postoperative hydrotubation (flushing out of the fallopian tubes) have been used to improve the results of tubal surgery. The review of trials found there is insufficient evidence to support the routine practice of hydrotubation or this second-look laparoscopy after pelvic reproductive surgery. More research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-10-29 11:42:45 +1300" MODIFIED_BY="jane clarke">
<ABS_BACKGROUND MODIFIED="2008-08-27 23:14:45 +1200" MODIFIED_BY="[Empty name]">
<P>Hydrotubation with oil-soluble contrast media for unexplained infertility and adhesiolysis for infertility due to peritubal adhesions are primary procedures that are of recognised benefit. It is less clear whether postoperative procedures such as hydrotubation or second-look laparoscopy with adhesiolysis are beneficial following pelvic reproductive surgery.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the value of postoperative hydrotubation and second-look laparoscopy with adhesiolysis following female pelvic reproductive surgery.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-10-29 11:42:45 +1300" MODIFIED_BY="jane clarke">
<P>We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register (August 2008), Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2007, Issue 2), MEDLINE (1966 to August 2008), EMBASE (1980 to August 2008), PsycINFO (1967 to August 2008), Current Contents (1993 to August 2008), Biological Abstracts (1969 to August 2008), CINAHL (1982 to August 2008) and reference lists of identified articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-08-27 23:34:13 +1200" MODIFIED_BY="[Empty name]">
<P>All randomised controlled trials in which a postoperative procedure was compared with a control group following pelvic reproductive surgery were considered for inclusion in the review.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-10-29 11:27:34 +1300" MODIFIED_BY="jane clarke">
<P>Five randomised controlled trials were identified and included in this updated review. An attempt was made to obtain further information from the authors of all five trials. All trials were assessed for quality. The studied outcomes were pregnancy, live birth, ectopic pregnancy and miscarriage rates, and the rates of tubal patency and procedure-related complications. Review authors extracted the data independently and the odds ratios (OR) were estimated for these dichotomous outcomes.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-10-29 11:33:45 +1300" MODIFIED_BY="jane clarke">
<P>Five randomised controlled trials were identified and included in this review. The odds of pregnancy (OR 1.12, 95% confidence interval (CI) 0.57 to 2.21) and live birth (OR 0.61, 95% CI 0.24 to 1.59) were not significantly different with postoperative hydrotubation versus no hydrotubation. The odds of pregnancy (OR 0.96, 95% CI 0.44 to 2.07) or live birth (OR 0.67, 95% CI 0.19 to 2.32) were also not significantly different with second-look laparoscopy and adhesiolysis versus no second-look laparoscopy. Whether hydrotubation was early or late and whether hydrotubation fluid contained steroid or not had no significant impact on the odds of pregnancy or live birth. Late antibiotic hydrotubation increased the odds of at least one patent fallopian tube when compared with early hydrotubation in women (OR 7.72, 95% CI 2.50 to 8.93). The odds of infective morbidity significantly increased with early hydrotubation when compared with late non-antibiotic hydrotubation (OR 4.72, 95% CI 2.50 to 8.93). When comparing late hydrotubation following tubal stent removal with early hydrotubation in women who had no tubal stenting, there was no significant difference in pregnancy or live birth rates.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-10-29 11:33:33 +1300" MODIFIED_BY="jane clarke">
<P>There is insufficient evidence to support the routine practice of hydrotubation or second-look laparoscopy following female pelvic reproductive surgery. The studies on which this conclusion is based were either of poor quality or underpowered. These interventions should be performed in the context of a good quality, adequately powered randomised controlled trial. Postoperative hydrotubation with fluid containing antibiotic may offer benefit over hydrotubation fluid without antibiotic following tubal surgery. A randomised controlled trial of postoperative hydrotubation with antibiotic-containing fluid versus no hydrotubation for improving fertility following tubal surgery is justified.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-12 08:56:50 +1300" MODIFIED_BY="jane clarke">
<BACKGROUND MODIFIED="2008-10-29 11:34:06 +1300" MODIFIED_BY="jane clarke">
<CONDITION MODIFIED="2008-10-29 11:18:05 +1300" MODIFIED_BY="jane clarke">
<P>Pelvic reproductive surgery may be defined as surgery on the pelvis that is intended to improve fertility. It may include surgery on the uterus, ovaries, pelvic peritoneum (in the case of endometriosis), and most commonly the fallopian tubes. A variety of procedures are collectively known as tubal surgery. Salpingo-ovariolysis is division of adhesions involving the fallopian tube and ovary; salpingostomy is the refashioning of a distal tubal ostium for distal tubal occlusion, and is designed to keep the fallopian tube open; tubal reanastomosis is the rejoining of fallopian tubes, typically performed for reversal of sterilisation; cornual anastomosis and utero-tubal implantation are recognised surgical treatments for cornual occlusion. Whilst surgery on the fallopian tubes has been performed less frequently since the advent of in vitro fertilisation (<LINK REF="REF-Novy-1995" TYPE="REFERENCE">Novy 1995</LINK>) other types of pelvic reproductive surgery, including 'ovarian drilling' as a treatment for clomiphene-resistant polycystic ovarian syndrome, are being performed more widely.</P>
<P>The pregnancy and live birth rates following female pelvic reproductive surgery can be disappointing in spite of apparent normal anatomical relationships at the time of surgery and the restoration of fallopian tube patency in tubal surgery. Pre-existing damage to the sensitive fimbrial end of the fallopian tube and intrinsic inflammatory tubal damage limit the success of reproductive surgery (<LINK REF="REF-Strandell-1995" TYPE="REFERENCE">Strandell 1995</LINK>; <LINK REF="REF-Winston-1991" TYPE="REFERENCE">Winston 1991</LINK>). Other causes of failure to conceive following pelvic surgery include postoperative adhesion formation or (re)occlusion of the fallopian tubes. Failure to capture or to pass the released egg down the fallopian tube may then result.</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-10-29 11:18:13 +1300" MODIFIED_BY="jane clarke">
<P>Hydrotubation is the flushing of the fallopian tubes via transcervical instillation of fluid into the uterine cavity. It is widely used in the technique of hysterosalpingography to provide diagnostic information about the fallopian tubes when investigating infertility. Hydrotubation with oil-soluble contrast media is of proven primary benefit in infertile couples (<LINK REF="REF-Vandekerckhove-1998" TYPE="REFERENCE">Vandekerckhove 1998</LINK>), which may be due to the flushing out of occluding 'tubal plugs'. Hydrotubation could theoretically flush out debris which may accumulate within the lumen of the fallopian tube after tubal surgery and thus reduce the likelihood of tubal reocclusion. Grant (<LINK REF="REF-Grant-1971" TYPE="REFERENCE">Grant 1971</LINK>) claimed increased pregnancy rates in women undergoing early postoperative hydrotubation following tubal surgery.</P>
</INTERVENTION>
<THEORY MODIFIED="2008-10-29 11:18:23 +1300" MODIFIED_BY="jane clarke">
<P>Laparoscopy is widely used for diagnostic purposes in the investigation of infertility, usually in association with hydrotubation to determine tubal patency. It has the advantage over hysterosalpingography in that division of pelvic adhesions may be performed at the same time. Adhesiolysis, whether performed at laparotomy (<LINK REF="REF-Tulandi-1990" TYPE="REFERENCE">Tulandi 1990</LINK>) or laparoscopically (<LINK REF="REF-Reich-1987" TYPE="REFERENCE">Reich 1987</LINK>), is of primary benefit in tubal infertility. It has been claimed that following pelvic reproductive surgery second-look laparoscopy with adhesiolysis may increase the intrauterine pregnancy rate (<LINK REF="REF-Surrey-1982" TYPE="REFERENCE">Surrey 1982</LINK>) and decrease the ectopic pregnancy rate (<LINK REF="REF-Trimbos_x002d_Kemper-1985" TYPE="REFERENCE">Trimbos-Kemper 1985</LINK>) although others have failed to demonstrate increased pregnancy rates (<LINK REF="REF-Luber-1986" TYPE="REFERENCE">Luber 1986</LINK>; <LINK REF="REF-Gomel-1986" TYPE="REFERENCE">Gomel 1986</LINK>). Second-look laparoscopy is widely undertaken in the USA (<LINK REF="REF-DiZerega-2003" TYPE="REFERENCE">DiZerega 2003</LINK>).</P>
</THEORY>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-10-29 11:34:21 +1300" MODIFIED_BY="jane clarke">
<P>To assess the effectiveness and safety of postoperative procedures following female pelvic reproductive surgery in improving pregnancy and live birth outcomes.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-12 08:56:42 +1300" MODIFIED_BY="jane clarke">
<SELECTION_CRITERIA MODIFIED="2008-11-12 08:56:42 +1300" MODIFIED_BY="jane clarke">
<CRIT_STUDIES MODIFIED="2008-10-29 11:34:37 +1300" MODIFIED_BY="jane clarke">
<P>All randomised controlled trials (RCTs) were eligible for inclusion where a postoperative procedure was compared with a control group following pelvic reproductive surgery. Quasi-randomised trials were not included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-10-29 11:34:52 +1300" MODIFIED_BY="jane clarke">
<P>Women of reproductive years experiencing primary or secondary infertility who underwent pelvic reproductive surgery.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-11-12 08:56:42 +1300" MODIFIED_BY="jane clarke">
<P>The following interventions after pelvic reproductive surgery were analysed.</P>
<P>1. Hydrotubation versus no hydrotubation (with and without other intraoperative or postoperative interventions).</P>
<P>2. Different modalities of hydrotubation (e.g. fluid containing steroids or antibiotics).<BR/>
</P>
<P>3. Second-look laparoscopy with adhesiolysis versus no second-look laparoscopy (with and without other intraoperative or postoperative interventions).</P>
<P>4. Any other postoperative procedure.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-28 12:53:28 +1200" MODIFIED_BY="[Empty name]">
<P>The following rates should be defined within a given time period.</P>
<SUBSECTION>
<HEADING LEVEL="5">Primary outcomes</HEADING>
<P>1. Pregnancy rate (per woman)<BR/>2. Live birth rate (per woman)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<P>1. Ectopic pregnancy rate (per woman)<BR/>2. Miscarriage rate (per intrauterine pregnancy or per woman)<BR/>3. Infection rate<BR/>4. Other complications<BR/>5. Tubal patency rate, at least one fallopian tube remaining open</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-10-29 11:43:20 +1300" MODIFIED_BY="jane clarke">
<P>The search strategy of the Menstrual Disorders and Subfertility Group was used to identify all publications that described or might have described randomised trials of postoperative procedures following pelvic reproductive surgery.</P>
<P>We searched the electronic databases: the Cochrane Menstrual Disorders and Subfertility Group Trials Register (August 2008), Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2008, Issue 2), MEDLINE (1966 to August 2008), EMBASE (1988 to August 2008), and Biological Abstracts (1969 to August 2008). Reference lists of identified articles were searched and researchers in the field were contacted.</P>
<P>1. The Menstrual Disorders and Subfertility Group Trials Register was searched for any trial with any of the keywords in the title, abstract or keywords section. This Register is based on regular searches of MEDLINE, EMBASE, CINAHL, PsycINFO, and handsearching of 20 relevant journals and conference proceedings.</P>
<P>2. The MEDLINE and Biological Abstract databases were searched using the subject headings and keywords detailed in the abstracts <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.<BR/>
</P>
<P>3. The EMBASE database was searched using the same subject headings and keywords as detailed in the MEDLINE search strategy <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>.</P>
<P>5. CENTRAL was searched using the following keywords: pelvic surgery, tubal surgery, fertility surgery, reproductive surgery, postoperative, postoperative procedures, hydrotubation, hysterosalpingogram, HSG, postoperative laparoscopy, second-look laparoscopy,and adhesiolysis<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>6. The citation lists of relevant publications, review articles, and included studies were also searched.</P>
<P>For the included trials, either the first or corresponding author was contacted to clarify data extraction issues.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-12 08:56:24 +1300" MODIFIED_BY="jane clarke">
<P>Two review authors independently selected the trials to be included in accordance with the above-mentioned criteria. Disagreements were resolved by discussion.</P>
<P>Data were extracted and the trials were analysed for the following quality criteria, methodological details, and descriptive data of participants and outcomes. This information is presented in the table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>
<B>Trial characteristics </B>
</P>
<P>Each included trial was assessed for the following criteria: concealed assignment, technique of randomisation, time of randomisation (pre or intraoperatively), number of randomised patients, number of patients not randomised with explanation, exclusion from randomisation, the presence of blinding, documentation of dropouts, follow up, standardisation of outcome assessment, and whether the intention-to-treat analysis or power calculation was employed. This information was included in the table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>Two review authors performed the assessments of the quality of trials and data were extracted independently. All discrepancies were resolved by discussion. Additional information on trial methodology and trial data were sought from the authors of trials that appeared to meet the eligibility criteria but had aspects of methodology that were unclear, or data that were in a form that was unsuitable for meta-analysis.</P>
<P>Statistical analysis was performed in accordance with the guidelines for statistical analysis in Section 8 of the Cochrane Handbook for Systematic Reviews of Interventions <LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK> . Results for each study were expressed as odds ratios (OR) with 95% confidence intervals (CI) and were combined for meta-analysis with RevMan software.</P>
<P>The Chi<SUP>2</SUP> test was performed and the I<SUP>2</SUP> statistic calculated to determine whether there was significant heterogeneity.</P>
<P>This review shall be updated every two years as per the Cochrane Collaboration recommendations.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-10-29 11:40:12 +1300" MODIFIED_BY="jane clarke">
<STUDY_DESCRIPTION MODIFIED="2008-10-29 11:38:37 +1300" MODIFIED_BY="jane clarke">
<P>The selection of trials for inclusion in the review was performed by two review authors after employing the search strategy described previously. Differences of opinion were resolved by consensus. The search strategy yielded 607 studies. Of these 41 papers required closer scrutiny based on the title and abstract: 15 studies examined pregnancy outcome following the interventions and five of these were found to be RCTs eligible for inclusion. A single trial that met the eligibility criteria was excluded (<LINK REF="STD-Alborzi-2003" TYPE="STUDY">Alborzi 2003</LINK>) and has been discussed in the Discussion section of the review. The study could not be included as it randomised participants by alternation on admission.</P>
<P>Five RCTs with a total of 588 women met the criteria for inclusion in the review. All trials were published in full in peer-reviewed journals. Three trials examined postoperative hydrotubation (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>) and two trials examined second-look laparoscopy with adhesiolysis (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). Additional information has been sought for all five of these trials and was forthcoming, to date, only in two cases (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). The review authors are unaware of any ongoing trials relevant to this review. The year of publication of the included studies ranged from 1977 to 1992.</P>
<SUBSECTION>
<HEADING LEVEL="6">Trials examining postoperative hydrotubation</HEADING>
<P>Comninos (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>) randomised 30 women undergoing bilateral salpingostomy to early postoperative hydrotubation on the third, fifth, and seventh postoperative day versus peritubal irrigation on the third, fifth, and seventh postoperative day. Peritubal irrigation was via a prosthesis (the salpingostomy device of Cognat) that was attached to the serosa of the fallopian tube and uterine fundus and covered the distal portion of the tube. It was followed by three late hydrotubations three, five and seven days after removal of the prosthesis on the 12th postoperative day.</P>
<P>Rock (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) randomised 206 women undergoing bilateral distal tubal surgery (unilateral if only one residual fallopian tube) to three groups comparing postoperative hydrotubation with lactated Ringer's solution versus postoperative hydrotubation with lactated Ringer's solution containing hydrocortisone versus no hydrotubation in women undergoing tubal surgery. The hydrotubations were performed on the first and third postoperative day and on the day of discharge from hospital.</P>
<P>Soihet undertook a three-group parallel trial (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>) and randomised 258 women undergoing a variety of tubal surgical procedures into three groups: early postoperative hydrotubation (twice weekly from the fifth postoperative day to six weeks); late postoperative hydrotubation (twice weekly from the 6th to 12th postoperative week) where the surgery had included anterior uterine suspension and Teflon tube stenting of the fallopian tubes (electively removed after six weeks); and late postoperative hydrotubation (twice weekly from the 6th to 12th postoperative week) with a solution containing gentamicin where the surgery included tubal suspension in addition to anterior uterine suspension and tubal stenting as described above.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Trials examining second-look laparoscopy with adhesiolysis</HEADING>
<P>Gurgan (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) randomised 20 women undergoing laparoscopic Nd-YAG laser photocoagulation of the ovaries for clomiphene-resistant polycystic ovarian syndrome to second-look laparoscopy with adhesiolysis within three to four weeks of surgery versus no second-look laparoscopy.</P>
<P>Tulandi (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) randomised 74 women failing to conceive one year after terminal salpingostomy or salpingo-ovariolysis to second-look laparoscopy with adhesiolysis versus no second-look laparoscopy.</P>
<P>No power calculations were given in any paper although one author (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) stated in correspondence that a power calculation had been performed prior to the trial to determine sample size. No source of funding was stated for any of the trials. One trial was multicentre, involving five centres: three in the USA, one in the Netherlands, and one in Colombia (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>); four were single-centre trials (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). The timing and duration of the trial was given in the publication for one trial (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) and in correspondence for two trials (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>).</P>
<P>The important prognostic factors of women's ages and the duration of infertility were stated in all trials except Soihet (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>). Only one trial (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) specified the proportion of women with primary or secondary infertility. The investigative work up was described in all trials except Soihet (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>); these included semen analysis, assessments of likelihood of ovulation and of tubal patency. The results of these investigations were all normal in the couples in Comninos (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>) and not specified by Rock (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>). Tulandi (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) mentioned that all other investigations were normal and these were specified in correspondence. In Gurgan (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) five women had minimal endometriosis (three undergoing second-look laparoscopy and two controls) and four male partners had mild oligoasthenospermia (one partner of a woman undergoing second-look laparoscopy and three partners of women in the control group). The extent of the cause of infertility was defined in all trials: Comninos (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>) studied women with bilateral distal tubal occlusion; Rock (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) and Tulandi (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) confirmed tubal disease in all women, Rock (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) noted that mild tubal disease correlated with surgical success; Soihet (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>) studied women with tubal occlusion or immobility; Gurgan (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) studied women with polycystic ovarian syndrome resistant to high-dose clomiphene citrate but failed to specify their body mass indices. Only two trials stated previous fertility treatments that had been undertaken: the women in Comninos (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>) had all undergone 12 therapeutic hydrotubations in the three cycles prior to tubal surgery; Gurgan (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) had treated all women with clomiphene, in doses up to 200 mg. Exclusion criteria prior to randomisation were stated in only two trials: Comninos (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>) excluded women with fibroids, endometriosis, and ovarian cysts; Tulandi (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) excluded women with endometriosis.</P>
<P>The number of pregnancies was given and the pregnancy rate per woman could be extracted from the data in all trials; this was done for all outcomes in order to maintain homogeneity of outcomes, as far as possible, for this review. Ectopic pregnancy rates per woman (the number of women experiencing at least one ectopic pregnancy over the time period defined by the trial) could also be extracted from the data in all trials. Comparison of these rates per woman within a defined time period was, therefore, possible in all studies except one (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>). The preferable method of reporting success rates in any trial would be discrete time survival analysis, followed by continuous time survival analysis, then rates per woman within a given time period (used in this review). Only one trial expressed the outcomes in a continuous time survival analysis (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). Live birth rates were stated in two trials (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) and live birth rate plus ongoing pregnancy rate at the time of publication was stated in one (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>). Miscarriage rates were stated in three trials (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>), tubal patency rates in three trials (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK> in correspondence), post-treatment infection rates in four trials (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK> in correspondence; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) and post-treatment complication rates in three trials (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK> in correspondence; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK> in correspondence). The duration of follow up was stated in all trials except Soihet (1974) and in three trials the duration of follow up was 24 months or longer (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>).</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-10-29 11:39:06 +1300" MODIFIED_BY="jane clarke">
<P>The overall quality of the included trials was poor, particularly the oldest trials, by the standards of RCTs currently being undertaken see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<P>Of the five RCTs, three stated a genuine method of randomisation: a random number table (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>), a pack of cards (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>), computer-generated random numbers (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). Two trials had unusual numbers in their groups: Rock (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) had 86, 60, and 60 participants respectively; and Soihet (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>) had 67, 100, and 91 participants respectively, which raised concerns over the randomisation process. The uneven numbers per group could represent deliberate unequal randomisation (unlikely), failure to use permuted blocks (very likely), abuse of the process (also likely), post-randomisation exclusions (almost certain), or combinations of the above. The timing of randomisation was not stated in any of the three trials that examined postoperative hydrotubation; in the other two trials the randomisation took place: immediately after the initial surgery (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>), and one year after the initial surgery (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). Allocation concealment was adequate in two trials (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>, <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>), unclear in one trial (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>), and probably not used in the other two trials (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>). None of the trials used blinding and indeed by the nature of the interventions, hydrotubation or second-look laparoscopy, blinding would be difficult. However, Rock (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>) and Soihet (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>) could have built double-blinding into two arms of their studies. Scope for bias from not blinding includes the possibility of more thorough follow up by investigators to find outcomes in couples not attending follow-up clinics.</P>
<P>Withdrawals after randomisation were mentioned by only Gurgan (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>): one participant declined second-look laparoscopy and was excluded from the analysis. In this case an intention-to-treat analysis was not done by the authors but was possible and was performed in this review. Since no withdrawals or losses to follow up were mentioned in any of the other trials, it is likely that only women completing the study were used in the results analysis. This meant that an intention-to-treat analysis was probably not done and nor would be possible for those trials.</P>
<P>The effect of the intervention hydrotubation was seriously obscured by the presence of other interventions in the control groups, in two trials (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-10-29 11:40:12 +1300" MODIFIED_BY="jane clarke">
<P>Trial results have been combined for only five outcomes and with not more than two studies in any analysis. There was no evidence of statistical heterogeneity in any of the comparisons.</P>
<P>
<B>Hydrotubation versus no hydrotubation</B> (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>)<BR/>Based on 86 women in a single study, the intervention hydrotubation did not significantly alter the odds of pregnancy (OR 1.12, 95% CI 0.57 to 2.21), live birth (OR 0.61, 95% CI 0.24 to 1.59), ectopic pregnancy (OR 1.62, 95% CI 0.52 to 5.03), or miscarriage (OR 2.71, 95% CI 0.62 to 11.84). <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK> reported that there were no post-treatment infections or complications in either the treatment or control groups.</P>
<P>
<B>Hydrotubation with steroid versus hydrotubation without steroid</B> (<LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>)<BR/>Based on 60 women in a single study, the addition of hydrocortisone to the hydrotubation fluid did not significantly alter the odds of pregnancy (OR 0.82, 95% CI 0.35 to 1.95), live birth (OR 0.49, 95% CI 0.13 to 1.89), ectopic pregnancy (OR 2.04, 95% CI 0.53 to 7.91), or miscarriage (OR 1.19, 95% CI 0.17 to 8.21). <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK> reported that there were no post-treatment infections or complications in either the treatment or control groups.</P>
<P>
<B>Hydrotubation with antibiotic versus hydrotubation without antibiotic </B>(<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>)<BR/>Based on 55 women in a single study, the addition of gentamicin to the hydrotubation significantly increased the odds of pregnancy (OR 2.23, 95% CI 1.12 to 4.44) and live birth (OR 2.37, 95% CI 1.11 to 5.05); decreased the odds of infection (OR 0.12, 95% CI 0.05 to 0.28); but failed to significantly alter the odds of ectopic pregnancy (OR 1.39, 95% CI 0.37 to 5.30) or tubal patency (OR 0.86, 95% CI 0.48 to 1.55). However, the women who received hydrotubation with gentamicin received the additional intervention of tubal suspension at initial surgery. Soihet (1974) specifically stated febrile morbidity (infection) as one of the outcomes of the trial and reported infections in as many as 60% of women in the early hydrotubation group.</P>
<P>
<B>Early hydrotubation versus late non-antibiotic hydrotubation</B> (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>)<BR/>Based on 67 women in a single study, early hydrotubation when compared to late non-antibiotic hydrotubation was associated with significantly increased odds of infective morbidity (OR 4.72, 95% CI 2.50 to 8.93) and significantly reduced odds of patency of at least one fallopian tube at subsequent assessment (OR 0.29, 95% CI 0.16 to 0.55), which suggested a possible benefit with the use of late non-antibiotic hydrotubation following its removal. Early hydrotubation when compared to late non-antibiotic hydrotubation failed to significantly alter the odds of pregnancy (OR 1.11, 95% CI 0.48 to 2.61), live birth (OR 0.94, 95% CI 0.35 to 2.55), or ectopic pregnancy (OR 1.54, 95% CI 0.39 to 6.51).</P>
<P>
<B>Early hydrotubation versus tubal stenting </B>(<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>)<BR/>Based on 30 women in a single study, early hydrotubation when compared to tubal stenting failed to significantly alter the odds of pregnancy (OR 0.52, 95% CI 0.11 to 2.54), ectopic pregnancy (OR 1.00, 95% CI 0.06 to 16.79), miscarriage (OR 0.85, 95% CI 0.06 to 11.78), or miscarriage (OR 0.34, 95% Cl 0.08 to 1.44).</P>
<P>
<B>Second-look laparoscopy versus no second-look laparoscopy</B> (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>)<BR/>Whether considered both independently and combined in a meta-analysis, early second-look laparoscopy with adhesiolysis (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) and late second-look laparoscopy with adhesiolysis (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) did not significantly alter the odds of pregnancy (OR 0.96, 95% CI 0.44 to 2.07), live birth (OR 0.67, 95% CI 0.19 to 2.32), ectopic pregnancy (OR 1.49, 95% CI 0.46 to 4.79), or miscarriage (OR 1.27, 95% CI 0.15 to 10.88). <LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK> and <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK> reported that there were no post-treatment infections or complications in either treatment or control groups.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-12 08:56:50 +1300" MODIFIED_BY="jane clarke">
<P>This systematic review of RCTs has failed to show a significant benefit or detriment of hydrotubation or second-look laparoscopy with adhesiolysis following pelvic reproductive surgery. Hydrotubation with antibiotic versus hydrotubation without antibiotic may increase the odds of pregnancy and live birth while reducing the odds of infection. The use of a tubal stent or prosthesis followed, after its removal, by late hydrotubation may reduce the odds of infection and increase the odds of at least one fallopian tube remaining patent but there is no evidence that it improves fertility.</P>
<P>Whilst this review did not demonstrate a significant increase in the odds of infection or complications following the postoperative procedures, the interventions studied are not without invasive characteristics. Hydrotubation is uncomfortable, embarrassing, and carries a cost. Laparoscopy causes discomfort, carries the hazards of general anaesthesia and the rare but recognised hazards of gastrointestinal, urinary tract or vascular injury and, even when performed on a day-case basis, is costly for the health service and the patient. The interventions should not be performed without evidence of benefit.</P>
<P>Grant (<LINK REF="REF-Grant-1971" TYPE="REFERENCE">Grant 1971</LINK>) reported increased pregnancy rates in women undergoing postoperative hydrotubation with a solution containing hydrocortisone when compared to a control group but studied consecutive patients and used a historical control group. There are reports of a variety of types of hydrotubation fluid used postoperatively (<LINK REF="REF-Arronet-1969" TYPE="REFERENCE">Arronet 1969</LINK>; <LINK REF="REF-Jessen-1971" TYPE="REFERENCE">Jessen 1971</LINK>; <LINK REF="REF-Rock-1978" TYPE="REFERENCE">Rock 1978</LINK>) but no other studies have claimed benefit of postoperative hydrotubation over a control group. Whilst the number of women in the three trials examining postoperative hydrotubation was 474, there are quality concerns over all three trials (<LINK REF="STD-Comninos-1977" TYPE="STUDY">Comninos 1977</LINK>; <LINK REF="STD-Rock-1984" TYPE="STUDY">Rock 1984</LINK>; <LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>) and unfortunately none of the authors of these trials responded to requests for additional information. It is difficult to obtain reliable data from the 'oldest' trials, which tend to be the poorest quality trials and the least likely to be clarified in correspondence. The corresponding authors may no longer be contact able and if contact able they may be unlikely to make meaningful comments about research performed, in some cases, more than 20 years previously.</P>
<P>The apparent benefit of antibiotic in hydrotubation fluid was based on trial data from Soihet (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>), a trial of poor quality. In particular, the group of women receiving hydrotubation fluid containing gentamicin had also undergone tubal suspension as part of additional surgery (an additional intervention not performed in the control group). The trial author emphasised the importance of avoiding infection for the success of tubal surgery (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>). It may simply be that administration of antibiotic versus no antibiotic confers benefit following tubal stent removal six weeks after tubal surgery; with the route of antibiotic administration, in this case by hydrotubation, being coincidental. Increased odds of pregnancy and live birth in late hydrotubation after tubal stent removal, where hydrotubation fluid contains antibiotic versus no antibiotic, must therefore be interpreted cautiously. It is worthy of further evaluation.</P>
<P>A future RCT examining postoperative hydrotubation to improve fertility following tubal surgery would be justifiable if the hydrotubation fluid was to contain antibiotic, and if the trial was adequately powered. Live birth rates of 23% and 11% occurred with late postoperative hydrotubation with antibiotic and without antibiotic, respectively (<LINK REF="STD-Soihet-1974" TYPE="STUDY">Soihet 1974</LINK>). In order to have 80% power to detect such an increase in the live birth rate at the 95% confidence level, a trial would need to randomise 338 women undergoing postoperative hydrotubation with antibiotic versus no hydrotubation. This would be the absolute minimum number to confer sufficient weight to the results and conclusions of such a trial.</P>
<P>The total number of women in the two RCTs examining second-look laparoscopy (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>; <LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) was only 56. With underpowered studies, conclusions about the ineffectiveness of these procedures must be made cautiously as this is absence of evidence of benefit rather than evidence of absence of benefit. Much consideration was given to the pooling of data from the trials of Gurgan (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>) and Tulandi (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>) in a meta-analysis. The primary surgery was very different (tubal surgery compared with laser photocoagulation of polycystic ovaries), the participants differed in that the primary surgery had already failed to reverse infertility in those undergoing tubal surgery (not the case for the women undergoing ovarian photocoagulation), and in addition there was a difference in the timing of the second-look laparoscopy. The decision to pool the data was based on the fact that both trials used the single intervention of second-look laparoscopy with adhesiolysis; there was an absence of evidence with respect to early and late second-look laparoscopic division of adhesions, that one offers benefit over the other; and the fact that results of the trials were very similar.</P>
<P>The most appropriate time to perform postoperative pelvic adhesiolysis is uncertain and has varied from eight days to two years after the primary surgery (<LINK REF="REF-DeCherney-1984" TYPE="REFERENCE">DeCherney 1984</LINK>; <LINK REF="REF-Gomel-1986" TYPE="REFERENCE">Gomel 1986</LINK>; <LINK REF="REF-Raj-1982" TYPE="REFERENCE">Raj 1982</LINK>; <LINK REF="REF-Surrey-1982" TYPE="REFERENCE">Surrey 1982</LINK>; <LINK REF="REF-Trimbos_x002d_Kemper-1985" TYPE="REFERENCE">Trimbos-Kemper 1985</LINK>). It is very clear that, even with the most scrupulous of surgical techniques, adhesions do often form after pelvic reproductive surgery and that early second-look laparoscopy with adhesiolysis at a later date reduces the extent of such adhesions (<LINK REF="REF-Jansen-1988" TYPE="REFERENCE">Jansen 1988</LINK>; <LINK REF="REF-Raj-1982" TYPE="REFERENCE">Raj 1982</LINK>; <LINK REF="REF-Trimbos_x002d_Kemper-1985" TYPE="REFERENCE">Trimbos-Kemper 1985</LINK>). Jansen (1988) suggested the ideal time for early postoperative adhesiolysis would be between the time of serosal healing (eight days) and established adhesion fibrosis (21 days). Others have suggested these early fine fibrinous adhesions are a normal consequence of tissue repair and may eventually disappear with time, due to local release of breakdown mediators in the remodelling process (<LINK REF="REF-Gillett-1994" TYPE="REFERENCE">Gillett 1994</LINK>). In the RCTs of this review, early second-look laparoscopy with adhesiolysis was undertaken after three to four weeks (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>). Late second-look laparoscopy has additional diagnostic value in the rational planning of future fertility treatment, for example accelerating referral for in vitro fertilisation with women deemed unlikely to conceive based on the laparoscopic appearance of the pelvis. Late second-look laparoscopy was performed one year after the primary surgery in the RCT included in this review (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). It is also interesting to speculate, but premature to conclude, that the lysis of adhesions due to surgery gives a different outcome from the lysis of non-surgical adhesions, the latter considered beneficial based on non-randomised studies by Tulandi (<LINK REF="REF-Tulandi-1990" TYPE="REFERENCE">Tulandi 1990</LINK>) and Reich (<LINK REF="REF-Reich-1987" TYPE="REFERENCE">Reich 1987</LINK>).</P>
<P>Unfortunately, to the best of our knowledge, no further truly randomised studies examining second-look laparoscopy with adhesiolysis following pelvic reproductive surgery, which could have been included in the update of this review, have been published. A single study was published in 2003 which examined the place for second-look laparoscopy following laparoscopic salpingo-ovariolysis (<LINK REF="STD-Alborzi-2003" TYPE="STUDY">Alborzi 2003</LINK>). This study could not be included in this systematic review as patients were allocated on the basis of a quasi-randomisation technique. Forty-six women underwent second-look laparoscopy while 44 women did not undergo second-look laparoscopy following laparoscopic salpingo-ovariolysis. The study reported no difference in live birth rates when comparing those who underwent second-look laparoscopy (n = 11) and the women who did not (n = 15).</P>
<P>In future a RCT examining second-look laparoscopy with adhesiolysis following pelvic reproductive surgery would be justifiable if it had adequate power and was able to randomise to early (eight to 21 days postoperatively), late, or no second-look laparoscopy with adhesiolysis. The overall pregnancy rates (including with second-look laparoscopy and no second-look laparoscopy) were 45% following laparoscopic laser ovarian photocoagulation (with 40% live birth rate) (<LINK REF="STD-Gurgan-1992" TYPE="STUDY">Gurgan 1992</LINK>), 22% following salpingostomy (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>), and 61% following salpingo-ovariolysis (<LINK REF="STD-Tulandi-1989" TYPE="STUDY">Tulandi 1989</LINK>). An increase in the total pregnancy rate of 25% (risk ratio 1.25) would be clinically important after any of these procedures, giving pregnancy rates of 56%, 28%, and 76% respectively. In order to have 80% power to detect such increases in the total pregnancy rates at the 95% confidence level, a trial would need to randomise 652 women following laparoscopic laser ovarian photocoagulation, 2002 following salpingostomy, and 414 women following salpingo-ovariolysis to second-look laparoscopy with adhesiolysis or no second-look laparoscopy. RCTs with the three groups suggested above (early versus late second-look laparoscopy with adhesiolysis versus no second-look laparoscopy) could increase the power of the study.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-28 14:29:16 +1200" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-08-13 08:19:05 +1200" MODIFIED_BY="James M N Duffy">
<P>There is insufficient evidence to support the routine practice of postoperative hydrotubation or second-look laparoscopy with adhesiolysis following female pelvic reproductive surgery. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-28 14:29:16 +1200" MODIFIED_BY="[Empty name]">
<P>RCTs of higher quality and sufficient power should be undertaken to examine the interventions of early and late second-look laparoscopy with adhesiolysis and postoperative hydrotubation. In the case of postoperative hydrotubation, there is justification for a RCT of postoperative hydrotubation with antibiotic-containing fluid versus no hydrotubation for improving fertility following tubal surgery.</P>
<P>Evaluation of the outcomes in these trials should include pregnancy, live birth, ectopic pregnancy rates per woman, miscarriage rates per intrauterine pregnancy and also:<BR/>- patient satisfaction;<BR/>- cost;<BR/>- complications, although the serious laparoscopic complications are rare and would require large numbers to show significant results.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-08-28 00:09:32 +1200" MODIFIED_BY="[Empty name]">
<P>We would like to thank the members of the Cochrane Menstrual Disorders and Subfertility Review Group based in Auckland, New Zealand who assisted with this review. We wish to thank Patrick Vandekerckhove and Richard Lilford for their input into the initial draft of the protocol.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-08-28 00:10:19 +1200" MODIFIED_BY="[Empty name]">
<P>None known<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-28 13:31:34 +1200" MODIFIED_BY="[Empty name]">
<P>James Duffy<BR/>2008 update: Drafting of the update, performed and assessed the search strategy, updated the review as required.</P>
<P>Neil Johnson<BR/>Original review: Primary author, involved in every step of the review.<BR/>2008 update: Supervised the drafting of the update, provided advice as required, proof reading of the final draft.</P>
<P>Gaity Ahmad<BR/>2008 update: Drafting of the update, performed and assessed the search strategy, updated the review as required.</P>
<P>Andrew Watson<BR/>Original review: Involved with initial draft of the protocol, selection of trials for inclusion in the review, quality assessment of included trials, data extraction and proof reading the final draft.<BR/>2008 update: Supervised the drafting of the update, provided advice as required, proof reading of the final draft.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-10-29 11:26:05 +1300" MODIFIED_BY="jane clarke">
<P>The search string was redesigned.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-08-29 10:58:49 +1200" MODIFIED_BY="jane clarke">
<STUDIES MODIFIED="2008-08-29 10:58:49 +1200" MODIFIED_BY="jane clarke">
<INCLUDED_STUDIES MODIFIED="2008-08-28 00:19:13 +1200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Comninos-1977" MODIFIED="2008-08-28 00:17:32 +1200" MODIFIED_BY="[Empty name]" NAME="Comninos 1977" YEAR="1977">
<REFERENCE MODIFIED="2008-08-28 00:17:32 +1200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Comninos AC.&lt;br&gt;Salpingostomy: results of two different methods of treatment.&lt;br&gt;Fertil Steril 1977;28:1211-4.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:17:32 +1200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Comninos AC</AU>
<TI>Salpingostomy: results of two different methods of treatment</TI>
<SO>Fertility and Sterility</SO>
<YR>1977</YR>
<VL>28</VL>
<PG>1211-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gurgan-1992" MODIFIED="2008-08-28 00:18:22 +1200" MODIFIED_BY="[Empty name]" NAME="Gurgan 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-08-28 00:18:22 +1200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Gurgan T, Urman B, Aksu T, Yarali H, Develioglu O, Kisnisci H.&lt;br&gt;The effect of short-interval laparoscopic lysis of adhesions on pregnancy rates following Nd-YAG laser photocoagulation of polycystic ovaries.&lt;br&gt;Obstet Gynecol 1992;80:45-7.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:18:22 +1200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gurgan T, Urman B, Aksu T, Yarali H, Develioglu O, Kisnisci H</AU>
<TI>The effect of short-interval laparoscopic lysis of adhesions on pregnancy rates following Nd-YAG laser photocoagulation of polycystic ovaries</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>80</VL>
<PG>45-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rock-1984" MODIFIED="2008-08-28 00:18:45 +1200" MODIFIED_BY="[Empty name]" NAME="Rock 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-08-28 00:18:45 +1200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Rock JA, Siegler AM, Meisel MB, Haney AF, Rosenwaks Z, Pardo-Vargas F, et al.&lt;br&gt;The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial.&lt;br&gt;Fertil Steril 1984;42:373-6.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:18:45 +1200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rock JA, Siegler AM, Meisel MB, Haney AF, Rosenwaks Z, Pardo-Vargas F, et al</AU>
<TI>The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial</TI>
<SO>Fertility and Sterility</SO>
<YR>1984</YR>
<VL>42</VL>
<PG>373-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soihet-1974" NAME="Soihet 1974" YEAR="1974">
<REFERENCE NOTES="&lt;p&gt;Soihet S.&lt;br&gt;Three comparative techniques on tubo-plasty.&lt;br&gt;Int J Fertil 1974;19:111-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soihet S</AU>
<TI>Three comparative techniques on tubo-plasty</TI>
<SO>International Journal of Fertility</SO>
<YR>1974</YR>
<VL>19</VL>
<PG>111-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tulandi-1989" MODIFIED="2008-08-28 00:19:13 +1200" MODIFIED_BY="[Empty name]" NAME="Tulandi 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-08-28 00:19:13 +1200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Tulandi T, Falcone T, Kafka I.&lt;br&gt;Second-look laparoscopy one year following reproductive surgery.&lt;br&gt;Fertil Steril 1989;52:421-4.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:19:13 +1200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tulandi T, Falcone T, Kafka I</AU>
<TI>Second-look laparoscopy one year following reproductive surgery</TI>
<SO>Fertility and Sterility</SO>
<YR>1989</YR>
<VL>52</VL>
<PG>421-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-08-29 10:58:49 +1200" MODIFIED_BY="jane clarke">
<STUDY DATA_SOURCE="PUB" ID="STD-Alborzi-2003" MODIFIED="2008-08-29 10:58:49 +1200" MODIFIED_BY="jane clarke" NAME="Alborzi 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-29 10:58:49 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alborzi S, Motazedian S, Parsanezhad ME</AU>
<TI>Chance of adhesion formation after laparoscopic salpingo-ovariolysis: Is there a place for second-look laparoscopy?</TI>
<SO>Journal of the American Association of Laparoscopists</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>2</NO>
<PG>172-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-29 10:52:01 +1200" MODIFIED_BY="jane clarke">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-29 10:52:01 +1200" MODIFIED_BY="jane clarke">
<REFERENCE ID="REF-Arronet-1969" MODIFIED="2008-08-28 00:21:33 +1200" MODIFIED_BY="[Empty name]" NAME="Arronet 1969" NOTES="&lt;p&gt;Arronet GH, Eduljee SY, O'Brien JR. A nine-year survey of fallopian tube dysfunction in human infertility: diagnosis and therapy. Fertil Steril 1969;20:903-18.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:21:33 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Arronet GH, Eduljee SY, O'Brien JR</AU>
<TI>A nine-year survey of fallopian tube dysfunction in human infertility: diagnosis and therapy</TI>
<SO>Fertility and Sterility</SO>
<YR>1969</YR>
<VL>20</VL>
<PG>903-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeCherney-1984" MODIFIED="2008-08-28 00:22:03 +1200" MODIFIED_BY="[Empty name]" NAME="DeCherney 1984" NOTES="&lt;p&gt;DeCherney AH, Mezer HC. The nature of posttuboplasty pelvic adhesions as determined by early and late laparoscopy. Fertil Steril 1984;41:643-6.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:22:03 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>DeCherney AH, Mezer HC</AU>
<TI>The nature of posttuboplasty pelvic adhesions as determined by early and late laparoscopy</TI>
<SO>Fertility and Sterility</SO>
<YR>1984</YR>
<VL>41</VL>
<PG>643-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DiZerega-2003" MODIFIED="2008-08-28 00:22:38 +1200" MODIFIED_BY="[Empty name]" NAME="DiZerega 2003" TYPE="JOURNAL_ARTICLE">
<AU>DiZerega GS, Roth R, Johns DB</AU>
<TI>Quantitation of peritoneal adhesions and correlation with clinical outcomes</TI>
<SO>Infertility and Reproductive Medicine Clinics of North America</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>3</NO>
<PG>431-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gillett-1994" NAME="Gillett 1994" NOTES="&lt;p&gt;Gillett WR, James C, Jetha N, McComb PF. Removal of the ovarian surface epithelium from the rabbit ovary - a cause of adhesions following a standard injury. Hum Reprod 1994;9:497-500.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Gillett WR, James C, Jetha N, McComb PF</AU>
<TI>Removal of the ovarian surface epithelium from the rabbit ovary - a cause of adhesions following a standard injury</TI>
<SO>Human Reproduction</SO>
<YR>1994</YR>
<VL>9</VL>
<PG>497-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gomel-1986" NAME="Gomel 1986" NOTES="&lt;p&gt;Gomel V, Taylor PJ. Surgical endoscopy. In: Gomel V, Taylor PJ, Yuzpe AA, Rioux JE, editors. Laparoscopy and hysteroscopy in gynecologic practice. Chicago: Yearbook Medical Publishers; 1986. p158.&lt;/p&gt;" TYPE="BOOK_SECTION">
<AU>Gomel V, Taylor PJ</AU>
<TI>Surgical endoscopy</TI>
<SO>Laparoscopy and hysteroscopy in gynecologic practice</SO>
<YR>1986</YR>
<PG>p158</PG>
<ED>Gomel V, Taylor PJ, Yuzpe AA, Rioux JE</ED>
<PB>Yearbook Medical Publishers</PB>
<CY>Chicago</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grant-1971" MODIFIED="2008-08-28 00:23:17 +1200" MODIFIED_BY="[Empty name]" NAME="Grant 1971" NOTES="&lt;p&gt;Grant A. Infertility surgery of the oviduct. Fertil Steril 1971;22:496-503.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:23:17 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Grant A</AU>
<TI>Infertility surgery of the oviduct</TI>
<SO>Fertility and Sterility</SO>
<YR>1971</YR>
<VL>22</VL>
<PG>496-503</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-08-29 10:51:55 +1200" MODIFIED_BY="jane clarke" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>
<I>Cochrane Handbook for Systematic Reviews of Interventions</I> Version 5.0.0 [updated February 2008]</TI>
<SO>The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jansen-1988" MODIFIED="2008-08-28 00:23:49 +1200" MODIFIED_BY="[Empty name]" NAME="Jansen 1988" NOTES="&lt;p&gt;Jansen RP. Early laparoscopy after pelvic operations to prevent adhesions: safety and efficacy. Fertil Steril 1988;49:26-31.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:23:49 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Jansen RP</AU>
<TI>Early laparoscopy after pelvic operations to prevent adhesions: safety and efficacy</TI>
<SO>Fertility and Sterility</SO>
<YR>1988</YR>
<VL>49</VL>
<PG>26-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jessen-1971" NAME="Jessen 1971" NOTES="&lt;p&gt;Jessen H. Forty-five operations for sterility. Acta Obstet Gynecol Scand 1971;50:105-15.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Jessen H</AU>
<TI>Forty-five operations for sterility</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1971</YR>
<VL>50</VL>
<PG>105-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luber-1986" MODIFIED="2008-08-28 00:24:27 +1200" MODIFIED_BY="[Empty name]" NAME="Luber 1986" NOTES="&lt;p&gt;Luber K, Beeson CC, Kennedy JF, Villanueva B, Young PE. Results of microsurgical treatment of tubal infertility and early second-look laparoscopy in the post-pelvic inflammatory disease patient: implications for in vitro fertilisation. Am J Obstat Gynecol 1986;154:1264-70.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:24:27 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Luber K, Beeson CC, Kennedy JF, Villanueva B, Young PE</AU>
<TI>Results of microsurgical treatment of tubal infertility and early second-look laparoscopy in the post-pelvic inflammatory disease patient: implications for in vitro fertilisation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1986</YR>
<VL>154</VL>
<PG>1264-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Novy-1995" NAME="Novy 1995" NOTES="&lt;p&gt;Novy MJ. Tubal surgery or IVF - making the best choice in the 1990s. Int J Menopausal Stud 1995;40:292-7.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Novy MJ</AU>
<TI>Tubal surgery or IVF - making the best choice in the 1990s</TI>
<SO>International Journal of Menopausal Studies</SO>
<YR>1995</YR>
<VL>40</VL>
<PG>292-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Raj-1982" MODIFIED="2008-08-28 00:24:55 +1200" MODIFIED_BY="[Empty name]" NAME="Raj 1982" NOTES="&lt;p&gt;Raj SG, Hulka JF. Second-look laparoscopy in infertility surgery: therapeutic and prognostic value. Fertil Steril 1982;38:325-9.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:24:55 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Raj SG, Hulka JF</AU>
<TI>Second-look laparoscopy in infertility surgery: therapeutic and prognostic value</TI>
<SO>Fertility and Sterility</SO>
<YR>1982</YR>
<VL>38</VL>
<PG>325-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reich-1987" NAME="Reich 1987" NOTES="&lt;p&gt;Reich H. Laparoscopic treatment of extensive pelvic adhesions, including hydrosalpinges. J Reprod Med 1987;32:472-5.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Reich H</AU>
<TI>Laparoscopic treatment of extensive pelvic adhesions, including hydrosalpinges</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1987</YR>
<VL>32</VL>
<PG>472-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rock-1978" MODIFIED="2008-08-28 00:25:26 +1200" MODIFIED_BY="[Empty name]" NAME="Rock 1978" NOTES="&lt;p&gt;Rock JA, Katayama KP, Martin EJ, Woodruff JD, Jones HW Jr. Factors influencing the success of salpingostomy techniques for distal fimbrial obstruction. Obstet Gynecol 1978;52:591-6.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:25:26 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Rock JA, Katayama KP, Martin EJ, Woodruff JD, Jones HW Jr</AU>
<TI>Factors influencing the success of salpingostomy techniques for distal fimbrial obstruction</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1978</YR>
<VL>52</VL>
<PG>591-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strandell-1995" NAME="Strandell 1995" NOTES="&lt;p&gt;Strandell A, Bryman I, Janson PO, Thorburn J. Background scoring systems in relation to pregnancy outcome after fertility surgery. Acta Obstet Gynecol Scand 1995;74:281-7.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Strandell A, Bryman I, Janson PO, Thorburn J</AU>
<TI>Background scoring systems in relation to pregnancy outcome after fertility surgery</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1995</YR>
<VL>74</VL>
<PG>281-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Surrey-1982" NAME="Surrey 1982" NOTES="&lt;p&gt;Surrey MW, Friedman S. Second-look laparoscopy after reconstructive pelvic surgery for infertility. J Reprod Med 1982;27:658-60.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Surrey MW, Friedman S</AU>
<TI>Second-look laparoscopy after reconstructive pelvic surgery for infertility</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1982</YR>
<VL>27</VL>
<PG>658-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trimbos_x002d_Kemper-1985" MODIFIED="2008-08-28 00:26:05 +1200" MODIFIED_BY="[Empty name]" NAME="Trimbos-Kemper 1985" NOTES="&lt;p&gt;Trimbos-Kemper TCM, Trimbos JB, van Hall EV. Adhesion formation after tubal surgery: results of the eighth-day laparoscopy in 188 patients. Fertil Steril 1985;43:395-400.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:26:05 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Trimbos-Kemper TCM, Trimbos JB, van Hall EV</AU>
<TI>Adhesion formation after tubal surgery: results of the eighth-day laparoscopy in 188 patients</TI>
<SO>Fertility and Sterility</SO>
<YR>1985</YR>
<VL>43</VL>
<PG>395-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tulandi-1990" MODIFIED="2008-08-28 00:26:29 +1200" MODIFIED_BY="[Empty name]" NAME="Tulandi 1990" NOTES="&lt;p&gt;Tulandi T, Collins JA, Burrows E, Jarrell JF, McInnes RA, Wrixton W, Simpson CW. Treatment-dependent and treatment-independent pregnancy among women with periadnexal adhesions. Am J Obstet Gynecol 1990;162:354-7.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:26:29 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Tulandi T, Collins JA, Burrows E, Jarrell JF, McInnes RA, Wrixton W, Simpson CW</AU>
<TI>Treatment-dependent and treatment-independent pregnancy among women with periadnexal adhesions</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1990</YR>
<VL>162</VL>
<PG>354-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vandekerckhove-1998" MODIFIED="2008-08-19 10:58:21 +1200" MODIFIED_BY="jane clarke" NAME="Vandekerckhove 1998" NOTES="&lt;p&gt;Vandekerckhove P, Watson A, Lilford R, Harada T, Hughes E. Therapeutic effect of oil-soluble and water-soluble media used for tubal patency testing (hysterosalpingography or laparoscopy) on pregnancy rates in infertility patients (Cochrane Review). In: The Cochrane Library, Issue 3, 1998. Oxford: Update Software.&lt;/p&gt;" NOTES_MODIFIED="2008-08-19 10:58:21 +1200" NOTES_MODIFIED_BY="jane clarke" TYPE="COCHRANE_REVIEW">
<AU>Vandekerckhove P, Watson A, Lilford R, Harada T, Hughes E</AU>
<TI>Oil-soluble versus water-soluble media for assessing tubal patency with hysterosalpingography or laparoscopy in subfertile women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>3</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2008-08-19 10:58:21 +1200" MODIFIED_BY="jane clarke">
<IDENTIFIER MODIFIED="2008-08-19 10:58:21 +1200" MODIFIED_BY="jane clarke" TYPE="DOI" VALUE="10.1002/14651858.CD000092."/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Winston-1991" MODIFIED="2008-08-28 00:26:56 +1200" MODIFIED_BY="[Empty name]" NAME="Winston 1991" NOTES="&lt;p&gt;Winston RM, Margara RA. Microsurgical salpingostomy is not an obsolete procedure. Br J Obstet Gynaecol 1991;98:637-42.&lt;/p&gt;" NOTES_MODIFIED="2008-08-28 00:26:56 +1200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Winston RM, Margara RA</AU>
<TI>Microsurgical salpingostomy is not an obsolete procedure</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1991</YR>
<VL>98</VL>
<PG>637-42</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-10-29 11:29:58 +1300" MODIFIED_BY="jane clarke">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-10-29 11:29:58 +1300" MODIFIED_BY="jane clarke" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-10-29 11:29:58 +1300" MODIFIED_BY="jane clarke" STUDY_ID="STD-Comninos-1977">
<CHAR_METHODS MODIFIED="2008-08-28 13:28:38 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised trial (method not stated)<BR/>Time of randomisation: not stated<BR/>30 women analysed<BR/>No withdrawals after randomisation - stated<BR/>At least 24-month follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 11:29:58 +1300" MODIFIED_BY="jane clarke">
<P>Women with primary or secondary infertility and bilateral distal tubal occlusion undergoing macro surgical salpingostomy covered by antibiotics (not specified). Age range 21-30 years (mean not stated), duration of infertility 2-4 years (mean not stated). Infertility work-up revealed no other cause of infertility and included semen analysis, PCT, basal body temperature charting, cervical mucus examination, endometrial biopsy, HSG +/- laparoscopy. All women had had prior attempts at therapeutic hydrotubation with normal saline containing 50mg of hydrocortisone and 500mg of ampicillin four times over each of three cycles. Women with fibroids, endometriosis or ovarian cysts were excluded prior to randomisation. The trial was carried out at Marika Eliadi Maternity Hospital, Athens, Greece. Timing and duration not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-28 00:12:39 +1200" MODIFIED_BY="[Empty name]">
<P>Early postoperative hydrotubation on days 3, 5 and 7 (using normal saline with 50mg hydrocortisone but no antibiotics) versus intraoperative insertion of prosthesis (Cognat's device) followed by postoperative transabdominal peritubal irrigation via the device on days 3, 5 and 7 (using normal saline with 50mg hydrocortisone and antibiotics - not specified) followed by late postoperative hydrotubation (using normal saline with 50mg hydrocortisone but no antibiotics) following removal of the prosthesis on day 12</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-28 00:13:19 +1200" MODIFIED_BY="[Empty name]">
<P>Outcomes of relevance to this review:<BR/>Total pregnancy rate (per woman)<BR/>Ectopic pregnancy rate (per woman)<BR/>Miscarriage rate (per intrauterine pregnancy)<BR/>Method of diagnosis of pregnancy - not stated<BR/>Tubal patency rate (of at least 1 fallopian tube, per woman; assessed by HSG, or laparoscopy in some patients, during the first cycle after surgery)</P>
<P>Other outcomes:<BR/>Total number of pregnancies and total number of live births in each group - some women had more than one pregnancy<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-28 13:27:42 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gurgan-1992">
<CHAR_METHODS MODIFIED="2008-08-28 13:27:42 +1200" MODIFIED_BY="[Empty name]">
<P>Truly randomised (table of random numbers)<BR/>Time of randomisation: after initial laparoscopic ovarian drilling<BR/>40 women randomised<BR/>1 woman declined treatment after the randomisation - excluded from the analysis in the original study<BR/>6-month follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-28 13:27:28 +1200" MODIFIED_BY="[Empty name]">
<P>Women with polycystic ovarian syndrome resistant to clomiphene who underwent laparoscopic ovarian laser drilling. Mean age 25.2 years (range 21-31 years), mean duration of infertility 4.4 years. 33 women had primary and 7 had secondary infertility. Infertility work up consisted of semen analysis (normal in 36 men and mildly oligo-asthenospermic in 4 men) and normal HSG. No exclusion criteria prior to randomisation stated. The trial was carried out in 1991 at the University of Hecettepi, Ankara, Turkey, recruitment taking 6 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-28 00:14:25 +1200" MODIFIED_BY="[Empty name]">
<P>Postoperative second-look laparoscopy and adhesiolysis 3-4 weeks following surgery versus no second-look laparoscopy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcomes of relevance to this review:<BR/>Total pregnancy rate (per woman)<BR/>Live birth plus ongoing pregnancy rate (per woman)<BR/>Ectopic pregnancy rate (per woman)<BR/>Method of diagnosis of pregnancy: serum beta hCG levels and real time ultrasound<BR/>Miscarriage rate (per intrauterine pregnancy)</P>
<P>Other outcomes:<BR/>Ovulation rate (per woman)<BR/>Multiple pregnancy rate (per pregnancy)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-28 13:26:00 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rock-1984">
<CHAR_METHODS MODIFIED="2008-08-28 00:15:00 +1200" MODIFIED_BY="[Empty name]">
<P>Truly randomised (pack of cards)<BR/>Time of randomisation not stated<BR/>206 women analysed<BR/>No withdrawals after randomisation stated<BR/>24-months follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-28 00:15:09 +1200" MODIFIED_BY="[Empty name]">
<P>Women with primary or secondary infertility and distal tubal disease. All women underwent bilateral salpingoneostomy of fimbrioplasty (unilateral if only 1 residual tube). Mean age 28 years (all women were under 36 years old), mean duration of infertility 12 years (range 1-19 years). The infertility work up consisted of semen analysis, PCT, documentation of ovulation (method not stated), HSG and laparoscopy (90% of women). No exclusion criteria prior to randomisation stated. The trial was multicentre (5 centres) carried out from Jan 1978 to Dec 1981 in the USA (Baltimore, Brooklyn, Durham), Netherlands (Amsterdam) and Colombia (Bogota).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-28 13:26:00 +1200" MODIFIED_BY="[Empty name]">
<P>Postoperative hydrotubation on 1st, 2nd and 3rd postoperative days and on the day of discharge home with 50mls Ringer's lactate versus 50ml Ringers lactate with 150mg hydrocortisone versus no hydrotubation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-28 00:15:35 +1200" MODIFIED_BY="[Empty name]">
<P>Outcomes of relevance to this review:<BR/>Total pregnancy rate (per woman)<BR/>Live birth rate (per woman)<BR/>Miscarriage rate (per woman; rate per intrauterine pregnancy extrapolated)<BR/>Ectopic pregnancy rate (per woman)<BR/>Method of diagnosis of pregnancy - not stated<BR/>Infection and complication rates (per woman)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-28 13:25:26 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Soihet-1974">
<CHAR_METHODS MODIFIED="2008-08-28 00:16:02 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised trial (method not stated)<BR/>Time of randomisation - not stated<BR/>258 women analysed<BR/>No withdrawals after randomisation stated<BR/>Duration of follow up - not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-28 13:25:26 +1200" MODIFIED_BY="[Empty name]">
<P>Women with primary or secondary infertility with tubal immobility or occlusion. All women underwent tubal surgery involving cuff salpingostomy, tubal reanastomosis, tubal reimplantation, adhesiolysis or any combination of the above, in addition to ventrosuspension, by laparotomy. The procedure was covered by intraperitoneal instillation of chloramphenicol or penicillin and the same antibiotics systemically for 5 days. Mean age and mean duration of infertility not specified. Infertility work up not stated. No exclusion criteria prior to randomisation stated. The trial was carried out at San Marcos University, Lima, Peru. Timing and duration of trial not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-28 13:25:06 +1200" MODIFIED_BY="[Empty name]">
<P>Early postoperative hydrotubation (solution not specified) twice weekly from day 5 to 6 weeks versus late postoperative hydrotubation twice weekly from weeks 6-12 where the surgery had included Teflon stenting of the fallopian tubes (removed electively after 6 weeks) versus late postoperative hydrotubation twice weekly from week 6-12 with a solution containing gentamicin where the surgery included tubal suspension in addition to Teflon tube stenting of the fallopian tubes (removed electively after 6 weeks)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcomes of relevance to this review:<BR/>Pregnancy or live birth rate (per woman)<BR/>Ectopic pregnancy rate (per woman)<BR/>Method of diagnosis of pregnancy: term delivery<BR/>Tubal patency rate (of at least 1 fallopian tube, per woman)<BR/>Infective morbidity rate (per woman)</P>
<P>Other outcomes:<BR/>Bilateral tubal obstruction rate (per woman)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-28 13:23:36 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tulandi-1989">
<CHAR_METHODS MODIFIED="2008-08-28 00:16:37 +1200" MODIFIED_BY="[Empty name]">
<P>Truly randomised (computer-generated random numbers)<BR/>Time of randomisation: 1 year after initial surgery<BR/>74 women randomised<BR/>Some women lost to follow up after randomisation - taken into account in life-table analysis<BR/>Duration of follow up: 36 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-28 13:23:15 +1200" MODIFIED_BY="[Empty name]">
<P>Women who had failed to conceive within 12 months of undergoing tubal microsurgery with instillation of 32% dextran (38 had salpingo-ovariolysis and 36 bilateral terminal salpingostomy). Mean age 30 years, duration of infertility at least 1 year prior to initial surgery. Other than tubal factor, further infertility work-up (semen analysis, endometrial biopsy, luteal phase progesterone) was normal. HSG performed preoperatively in all women. Women with endometriosis were excluded from entry into the study. The trial was carried out over 2 years from 1986-1988 at the Fertility Centre, McGill University, Montreal, Canada.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-28 13:23:36 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic tubal patency testing +/- laparoscopic adhesiolysis where indicated versus no laparoscopy 12 months after initial tubal microsurgery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcomes of relevance to this review:<BR/>Cumulative probability of pregnancy, live birth and ectopic pregnancy at 12, 24 and 36 months - rates per woman could be calculated<BR/>Method of diagnosis of pregnancy: urine pregnancy test and ultrasound<BR/>Ectopic pregnancy rate<BR/>Tubal patency rate (of at least 1 fallopian tube, per woman)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>HSG hysterosalpingogram</P>
<P>PCT postcoital test</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Alborzi-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>The study was quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-08-14 00:17:55 +1200" MODIFIED_BY="James M N Duffy">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2008-08-14 00:12:53 +1200" MODIFIED_BY="James M N Duffy" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:12:53 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Comninos-1977">
<DESCRIPTION>
<P>Study stated as randomised.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:09:47 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Gurgan-1992">
<DESCRIPTION>
<P>Random number tables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:10:03 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Rock-1984">
<DESCRIPTION>
<P>A pack of cards.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:12:00 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Soihet-1974">
<DESCRIPTION>
<P>Study stated as randomised.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:11:16 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Tulandi-1989">
<DESCRIPTION>
<P>Computer generated random number tables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-08-14 00:14:51 +1200" MODIFIED_BY="James M N Duffy" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:14:39 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Comninos-1977">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:13:37 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Gurgan-1992">
<DESCRIPTION>
<P>Opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:14:46 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Rock-1984">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:14:51 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Soihet-1974">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:14:00 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Tulandi-1989">
<DESCRIPTION>
<P>Opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2008-08-14 00:15:24 +1200" MODIFIED_BY="James M N Duffy" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-08-14 00:15:15 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Comninos-1977">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-08-14 00:15:17 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Gurgan-1992">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-08-14 00:15:19 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Rock-1984">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-08-14 00:15:21 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Soihet-1974">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-08-14 00:15:24 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Tulandi-1989">
<DESCRIPTION>
<P>Not stated within text.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2008-08-14 00:16:18 +1200" MODIFIED_BY="James M N Duffy" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-14 00:16:18 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Comninos-1977">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-14 00:16:10 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Gurgan-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-14 00:16:06 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Rock-1984">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-14 00:16:01 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Soihet-1974">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-14 00:15:41 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Tulandi-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2008-08-14 00:17:55 +1200" MODIFIED_BY="James M N Duffy" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:16:14 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Comninos-1977">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:16:10 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Gurgan-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:17:29 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Rock-1984">
<DESCRIPTION>
<P>Unequal numbers randomised into each group could represent deliberate unequal randomisation. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:17:50 +1200" MODIFIED_BY="James M N Duffy" RESULT="UNKNOWN" STUDY_ID="STD-Soihet-1974">
<DESCRIPTION>
<P>Unequal numbers randomised into each group could represent deliberate unequal randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:17:55 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Tulandi-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2008-08-14 00:16:13 +1200" MODIFIED_BY="James M N Duffy" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:16:13 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Comninos-1977">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:16:09 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Gurgan-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:16:04 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Rock-1984">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:15:56 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Soihet-1974">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-14 00:15:35 +1200" MODIFIED_BY="James M N Duffy" RESULT="YES" STUDY_ID="STD-Tulandi-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-12 08:59:16 +1300" MODIFIED_BY="jane clarke">
<COMPARISON ID="CMP-001" MODIFIED="2008-11-12 08:57:39 +1300" MODIFIED_BY="jane clarke" NO="1">
<NAME>Hydrotubation (all types) versus no hydrotubation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.212540706741412" CI_START="0.5682006264282143" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1212345943505286" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.3448912696751929" LOG_CI_START="-0.24549829181307095" LOG_EFFECT_SIZE="0.04969648893106102" METHOD="PETO" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.7414279891375992" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="86" WEIGHT="100.0" Z="0.32996290861727656">
<NAME>Total pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2125407067414122" CI_START="0.5682006264282142" EFFECT_SIZE="1.1212345943505286" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="17" LOG_CI_END="0.34489126967519296" LOG_CI_START="-0.245498291813071" LOG_EFFECT_SIZE="0.04969648893106102" ORDER="14068" O_E="0.9514563106796103" SE="0.3467977508936687" STUDY_ID="STD-Rock-1984" TOTAL_1="120" TOTAL_2="86" VAR="8.314716680958872" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.5904888717056276" CI_START="0.2356741327154845" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6122394020584213" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.20153063479280278" LOG_CI_START="-0.6276880824541232" LOG_EFFECT_SIZE="-0.2130787238306602" METHOD="PETO" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.3138015149419393" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="86" WEIGHT="100.0" Z="1.0072773705986888">
<NAME>Livebirth rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5904888717056276" CI_START="0.2356741327154845" EFFECT_SIZE="0.6122394020584213" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.20153063479280278" LOG_CI_START="-0.6276880824541232" LOG_EFFECT_SIZE="-0.2130787238306602" ORDER="14069" O_E="-2.067961165048544" SE="0.48708717920969447" STUDY_ID="STD-Rock-1984" TOTAL_1="120" TOTAL_2="86" VAR="4.214893475167195" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.030711673974137" CI_START="0.5186309681503017" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.6152655713405866" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.7016294272461846" LOG_CI_START="-0.28514155448675016" LOG_EFFECT_SIZE="0.20824393637971716" METHOD="PETO" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.40809829321914826" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="86" WEIGHT="100.0" Z="0.827244868077323">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.030711673974137" CI_START="0.5186309681503017" EFFECT_SIZE="1.6152655713405866" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.7016294272461846" LOG_CI_START="-0.28514155448675016" LOG_EFFECT_SIZE="0.20824393637971716" ORDER="14070" O_E="1.4271844660194173" SE="0.5796341592650631" STUDY_ID="STD-Rock-1984" TOTAL_1="120" TOTAL_2="86" VAR="2.9764052150842932" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="11.841571570359243" CI_START="0.6218619958341061" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.713636550932348" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="1.0734093441978692" LOG_CI_START="-0.20630598363327843" LOG_EFFECT_SIZE="0.4335516802822954" METHOD="PETO" MODIFIED="2008-11-12 08:57:39 +1300" MODIFIED_BY="jane clarke" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.18417051690308792" Q="0.0" RANDOM="NO" SCALE="14.166101864710319" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="13" WEIGHT="100.0" Z="1.3280229755945274">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.841571570359243" CI_START="0.6218619958341063" EFFECT_SIZE="2.713636550932348" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="1.0734093441978692" LOG_CI_START="-0.20630598363327826" LOG_EFFECT_SIZE="0.4335516802822954" ORDER="14071" O_E="1.7666666666666666" SE="0.7517111182610533" STUDY_ID="STD-Rock-1984" TOTAL_1="17" TOTAL_2="13" VAR="1.7696934865900382" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="86" WEIGHT="0.0" Z="0.0">
<NAME>Infection rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14072" O_E="0.0" SE="0.0" STUDY_ID="STD-Rock-1984" TOTAL_1="120" TOTAL_2="86" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="86" WEIGHT="0.0" Z="0.0">
<NAME>Complication rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14073" O_E="0.0" SE="0.0" STUDY_ID="STD-Rock-1984" TOTAL_1="120" TOTAL_2="86" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-08-19 10:46:27 +1200" MODIFIED_BY="jane clarke" NO="2">
<NAME>Hydrotubation with steroid versus hydrotubation without steroid</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.954642201954174" CI_START="0.3465484899410922" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8230299529557538" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.2910672712264403" LOG_CI_START="-0.4602359892182143" LOG_EFFECT_SIZE="-0.08458435899588702" METHOD="PETO" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6589818902329019" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.44131925419630885">
<NAME>Total pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.954642201954174" CI_START="0.3465484899410922" EFFECT_SIZE="0.8230299529557538" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.2910672712264403" LOG_CI_START="-0.4602359892182143" LOG_EFFECT_SIZE="-0.08458435899588702" ORDER="14074" O_E="-1.0" SE="0.4413192541963088" STUDY_ID="STD-Rock-1984" TOTAL_1="60" TOTAL_2="60" VAR="5.1344537815126055" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.893060865896807" CI_START="0.12648589812754946" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.48933169101650675" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.2771645776712267" LOG_CI_START="-0.8979578911425417" LOG_EFFECT_SIZE="-0.31039665673565753" METHOD="PETO" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.30047789717204454" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001" Z="1.035409132696864">
<NAME>Livebirth rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.893060865896807" CI_START="0.12648589812754946" EFFECT_SIZE="0.48933169101650675" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2771645776712267" LOG_CI_START="-0.8979578911425417" LOG_EFFECT_SIZE="-0.31039665673565753" ORDER="14075" O_E="-1.5" SE="0.6902727551312428" STUDY_ID="STD-Rock-1984" TOTAL_1="60" TOTAL_2="60" VAR="2.098739495798319" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.906019681273809" CI_START="0.5282450332236234" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.0436035890556425" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.8979578911425417" LOG_CI_START="-0.27716457767122665" LOG_EFFECT_SIZE="0.3103966567356575" METHOD="PETO" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.30047789717204454" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001" Z="1.035409132696864">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.906019681273809" CI_START="0.5282450332236234" EFFECT_SIZE="2.0436035890556425" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8979578911425417" LOG_CI_START="-0.27716457767122665" LOG_EFFECT_SIZE="0.3103966567356575" ORDER="14076" O_E="1.5" SE="0.6902727551312428" STUDY_ID="STD-Rock-1984" TOTAL_1="60" TOTAL_2="60" VAR="2.098739495798319" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.207957770040979" CI_START="0.17175782302558062" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1873419718295728" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.9142351133275176" LOG_CI_START="-0.7650834730779161" LOG_EFFECT_SIZE="0.07457582012480078" METHOD="PETO" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.8618044331226797" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="6" TOTAL_2="11" WEIGHT="100.0" Z="0.17407765595569766">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.207957770040979" CI_START="0.17175782302558062" EFFECT_SIZE="1.1873419718295728" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.9142351133275176" LOG_CI_START="-0.7650834730779161" LOG_EFFECT_SIZE="0.07457582012480078" ORDER="14077" O_E="0.17647058823529393" SE="0.986440050415621" STUDY_ID="STD-Rock-1984" TOTAL_1="6" TOTAL_2="11" VAR="1.0276816608996542" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Infection rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14078" O_E="0.0" SE="0.0" STUDY_ID="STD-Rock-1984" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="120" WEIGHT="0.0" Z="0.0">
<NAME>Complication rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14079" O_E="0.0" SE="0.0" STUDY_ID="STD-Rock-1984" TOTAL_1="120" TOTAL_2="120" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-11-12 08:58:28 +1300" MODIFIED_BY="jane clarke" NO="3">
<NAME>Hydrotubation with antibiotic versus hydrotubation without antibiotic</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.439704400256218" CI_START="1.117463569925457" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.2273769165823896" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.647354055337317" LOG_CI_START="0.04823337373843451" LOG_EFFECT_SIZE="0.3477937145378758" METHOD="PETO" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.022873232639648675" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="100" WEIGHT="100.0" Z="2.275545396711982">
<NAME>Total pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.439704400256218" CI_START="1.117463569925457" EFFECT_SIZE="2.2273769165823896" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="15" LOG_CI_END="0.647354055337317" LOG_CI_START="0.04823337373843451" LOG_EFFECT_SIZE="0.3477937145378758" ORDER="14080" O_E="6.465968586387433" SE="0.3519264540663877" STUDY_ID="STD-Soihet-1974" TOTAL_1="91" TOTAL_2="100" VAR="8.074138087742863" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.051689909298764" CI_START="1.1085386967318622" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.366430592336811" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.7034366841608793" LOG_CI_START="0.04475085801323593" LOG_EFFECT_SIZE="0.3740937710870576" METHOD="PETO" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.025995274203170837" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="100" WEIGHT="100.0" Z="2.226282361227115">
<NAME>Livebirth rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decrease odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.051689909298763" CI_START="1.1085386967318622" EFFECT_SIZE="2.366430592336811" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" LOG_CI_END="0.7034366841608792" LOG_CI_START="0.04475085801323593" LOG_EFFECT_SIZE="0.3740937710870576" ORDER="14081" O_E="5.7539267015706805" SE="0.38691531482655056" STUDY_ID="STD-Soihet-1974" TOTAL_1="91" TOTAL_2="100" VAR="6.679872291127754" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.29966997944447" CI_START="0.3658883090431694" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.3925111443955431" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.7242488260972638" LOG_CI_START="-0.43665146698006296" LOG_EFFECT_SIZE="0.1437986795586004" METHOD="PETO" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.627283000750261" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="100" WEIGHT="100.0" Z="0.48555459007106944">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.29966997944447" CI_START="0.3658883090431694" EFFECT_SIZE="1.3925111443955431" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.7242488260972638" LOG_CI_START="-0.43665146698006296" LOG_EFFECT_SIZE="0.1437986795586004" ORDER="14082" O_E="0.7120418848167542" SE="0.6819185787027516" STUDY_ID="STD-Soihet-1974" TOTAL_1="91" TOTAL_2="100" VAR="2.15047775410127" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.27529302631151914" CI_START="0.04830023287771033" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.11531139267416733" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-0.5602047899607776" LOG_CI_START="-1.316050775309342" LOG_EFFECT_SIZE="-0.9381277826350599" METHOD="PETO" MODIFIED="2008-11-12 08:58:28 +1300" MODIFIED_BY="jane clarke" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="1.1430178099498829E-6" Q="0.0" RANDOM="NO" SCALE="23.88289754397344" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="100" WEIGHT="100.0" Z="4.865268063872055">
<NAME>Infection rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.27529302631151914" CI_START="0.04830023287771033" EFFECT_SIZE="0.11531139267416733" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="23" LOG_CI_END="-0.5602047899607776" LOG_CI_START="-1.316050775309342" LOG_EFFECT_SIZE="-0.9381277826350599" ORDER="14083" O_E="-10.958115183246074" SE="0.4439876732917164" STUDY_ID="STD-Soihet-1974" TOTAL_1="91" TOTAL_2="100" VAR="5.072921881469663" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.5518434970453518" CI_START="0.47899499168339904" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8621631301332568" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="65" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="0.19084792066135456" LOG_CI_START="-0.31966902749490356" LOG_EFFECT_SIZE="-0.0644105534167745" METHOD="PETO" MODIFIED="2008-08-19 10:49:14 +1200" MODIFIED_BY="jane clarke" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.6209059491119622" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="100" WEIGHT="100.0" Z="0.49456679304026263">
<NAME>Tubal patency rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5518434970453523" CI_START="0.478994991683399" EFFECT_SIZE="0.8621631301332568" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="65" LOG_CI_END="0.19084792066135473" LOG_CI_START="-0.3196690274949036" LOG_EFFECT_SIZE="-0.0644105534167745" ORDER="14084" O_E="-1.6492146596858603" SE="0.29988018244663606" STUDY_ID="STD-Soihet-1974" TOTAL_1="91" TOTAL_2="100" VAR="11.119991805395456" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-08-19 10:49:11 +1200" MODIFIED_BY="jane clarke" NO="4">
<NAME>Early hydrotubation versus late hydrotubation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.606827325373322" CI_START="0.47535595321439883" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.113180528089751" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.4161122647236891" LOG_CI_START="-0.3229810627470271" LOG_EFFECT_SIZE="0.046565600988330985" METHOD="PETO" MODIFIED="2008-08-13 06:15:25 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8049315227958881" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="67" TOTAL_2="100" WEIGHT="100.0" Z="0.24696989531192218">
<NAME>Total pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.606827325373322" CI_START="0.47535595321439883" EFFECT_SIZE="1.113180528089751" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="15" LOG_CI_END="0.4161122647236891" LOG_CI_START="-0.3229810627470271" LOG_EFFECT_SIZE="0.046565600988330985" ORDER="14086" O_E="0.5688622754491011" SE="0.43414707912727435" STUDY_ID="STD-Soihet-1974" TOTAL_1="67" TOTAL_2="100" VAR="5.305498950875394" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.5542422298031404" CI_START="0.3492672485902047" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9445174195515147" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.4072620808986017" LOG_CI_START="-0.4568421370174385" LOG_EFFECT_SIZE="-0.024790028059418403" METHOD="PETO" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.9104605520101744" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="67" TOTAL_2="100" WEIGHT="100.0" Z="0.11245764379990184">
<NAME>Livebirth rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5542422298031404" CI_START="0.3492672485902047" EFFECT_SIZE="0.9445174195515147" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.4072620808986017" LOG_CI_START="-0.4568421370174385" LOG_EFFECT_SIZE="-0.024790028059418403" ORDER="14087" O_E="-0.2215568862275452" SE="0.5075790949887454" STUDY_ID="STD-Soihet-1974" TOTAL_1="67" TOTAL_2="100" VAR="3.881437039347465" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.513921721470654" CI_START="0.36233284008990063" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.5362967673804944" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.8138425352946185" LOG_CI_START="-0.4408923018377291" LOG_EFFECT_SIZE="0.18647511672844475" METHOD="PETO" MODIFIED="2008-08-13 06:15:32 +1200" MODIFIED_BY="James M N Duffy" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.5601838007182978" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="67" TOTAL_2="100" WEIGHT="100.0" Z="0.5825685268067573">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.513921721470654" CI_START="0.36233284008990063" EFFECT_SIZE="1.5362967673804944" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.8138425352946185" LOG_CI_START="-0.4408923018377291" LOG_EFFECT_SIZE="0.18647511672844475" ORDER="14089" O_E="0.7904191616766467" SE="0.7370374543691551" STUDY_ID="STD-Soihet-1974" TOTAL_1="67" TOTAL_2="100" VAR="1.8408605197800056" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.929508965852575" CI_START="2.500207087614867" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="4.724999640777247" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.9508275776697387" LOG_CI_START="0.39797598198549555" LOG_EFFECT_SIZE="0.6744017798276172" METHOD="PETO" MODIFIED="2008-08-19 10:49:11 +1200" MODIFIED_BY="jane clarke" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="1.7376276049595397E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="67" TOTAL_2="100" WEIGHT="100.0" Z="4.781764979572487">
<NAME>Infection rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.929508965852575" CI_START="2.500207087614867" EFFECT_SIZE="4.724999640777247" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="23" LOG_CI_END="0.9508275776697387" LOG_CI_START="0.39797598198549555" LOG_EFFECT_SIZE="0.6744017798276172" ORDER="14091" O_E="14.724550898203592" SE="0.3247477639644593" STUDY_ID="STD-Soihet-1974" TOTAL_1="67" TOTAL_2="100" VAR="9.482168337734747" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.5459871384637281" CI_START="0.15866138720563822" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.29432478112638083" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="65" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-0.2628175876249712" LOG_CI_START="-0.7995287529168509" LOG_EFFECT_SIZE="-0.531173170270911" METHOD="PETO" MODIFIED="2008-08-19 10:49:11 +1200" MODIFIED_BY="jane clarke" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="1.0467973870054983E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="67" TOTAL_2="100" WEIGHT="100.0" Z="3.879480624252624">
<NAME>Tubal patency rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5459871384637281" CI_START="0.15866138720563822" EFFECT_SIZE="0.29432478112638083" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="65" LOG_CI_END="-0.2628175876249712" LOG_CI_START="-0.7995287529168509" LOG_EFFECT_SIZE="-0.531173170270911" ORDER="14093" O_E="-12.305389221556887" SE="0.31526679525556606" STUDY_ID="STD-Soihet-1974" TOTAL_1="67" TOTAL_2="100" VAR="10.061055293640408" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-11-12 08:58:59 +1300" MODIFIED_BY="jane clarke" NO="5">
<NAME>Early hydrotubation versus tubal stent</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.5398229353425337" CI_START="0.10537011876084396" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5173214129809031" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.4048034406813128" LOG_CI_START="-0.9772825304628721" LOG_EFFECT_SIZE="-0.2862395448907797" METHOD="PETO" MODIFIED="2008-08-13 06:16:15 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.4168810776174644" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" WEIGHT="99.99999999999999" Z="0.8118441408859889">
<NAME>Total pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.539822935342534" CI_START="0.10537011876084396" EFFECT_SIZE="0.5173214129809031" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.40480344068131285" LOG_CI_START="-0.9772825304628721" LOG_EFFECT_SIZE="-0.2862395448907797" ORDER="128" O_E="-1.0" SE="0.8118441408859888" STUDY_ID="STD-Comninos-1977" TOTAL_1="15" TOTAL_2="15" VAR="1.5172413793103448" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.791452884015825" CI_START="0.059554108087449854" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="1.2250882751858339" LOG_CI_START="-1.2250882751858339" LOG_EFFECT_SIZE="0.0" METHOD="PETO" MODIFIED="2008-11-12 08:58:49 +1300" MODIFIED_BY="jane clarke" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="22.943158213464002" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0" Z="0.0">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.79145288401582" CI_START="0.05955410808744988" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2250882751858339" LOG_CI_START="-1.2250882751858336" LOG_EFFECT_SIZE="0.0" ORDER="130" O_E="0.0" SE="1.439245834257849" STUDY_ID="STD-Comninos-1977" TOTAL_1="15" TOTAL_2="15" VAR="0.48275862068965514" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="11.778924704519607" CI_START="0.06119481318172891" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8490047684051771" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="1.0711056456116232" LOG_CI_START="-1.213285386710902" LOG_EFFECT_SIZE="-0.07108987054963938" METHOD="PETO" MODIFIED="2008-11-12 08:58:55 +1300" MODIFIED_BY="jane clarke" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.9029089106865814" Q="0.0" RANDOM="NO" SCALE="17.63979610567744" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4" TOTAL_2="7" WEIGHT="100.0" Z="0.12198750911856655">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.778924704519607" CI_START="0.06119481318172891" EFFECT_SIZE="0.8490047684051771" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="1.0711056456116232" LOG_CI_START="-1.213285386710902" LOG_EFFECT_SIZE="-0.07108987054963938" ORDER="132" O_E="-0.09090909090909083" SE="1.341862600304233" STUDY_ID="STD-Comninos-1977" TOTAL_1="4" TOTAL_2="7" VAR="0.5553719008264463" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4365474434677419" CI_START="0.08123648791661468" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.3416139180901606" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="0.15731997359005986" LOG_CI_START="-1.09024886064149" LOG_EFFECT_SIZE="-0.4664644435257149" METHOD="PETO" MODIFIED="2008-11-12 08:58:59 +1300" MODIFIED_BY="jane clarke" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.14274196749885582" Q="0.0" RANDOM="NO" SCALE="12.61928762647337" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0" Z="1.4656562175858798">
<NAME>Tubal patency rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4365474434677419" CI_START="0.08123648791661468" EFFECT_SIZE="0.3416139180901606" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.15731997359005986" LOG_CI_START="-1.09024886064149" LOG_EFFECT_SIZE="-0.4664644435257149" ORDER="135" O_E="-2.0" SE="0.73282810879294" STUDY_ID="STD-Comninos-1977" TOTAL_1="15" TOTAL_2="15" VAR="1.8620689655172413" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-11-12 08:59:16 +1300" MODIFIED_BY="jane clarke" NO="6">
<NAME>Second-look laparoscopy versus no second-look laparoscopy</NAME>
<DICH_OUTCOME CHI2="0.5741851021814762" CI_END="2.0602930330018583" CI_START="0.4744471005237716" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9886860248517013" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.31392899394443935" LOG_CI_START="-0.3238122031130603" LOG_EFFECT_SIZE="-0.004941604584310476" METHOD="PETO" MODIFIED="2008-08-19 10:43:49 +1200" MODIFIED_BY="jane clarke" NO="1" P_CHI2="0.44860076953731953" P_Q="0.44860076953731953" P_Z="0.9757688016586402" Q="0.5741851021814762" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="58" WEIGHT="100.0" Z="0.030373973190925323">
<NAME>Total pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.0621077663069443" CI_START="0.4885946503029226" DF="0.0" EFFECT_SIZE="1.2231637148266803" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="0.4860204709765017" LOG_CI_START="-0.3110512924928315" LOG_EFFECT_SIZE="0.08748458924183507" MODIFIED="2008-08-13 02:40:50 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="1.0" P_Z="0.6670200352365139" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="38" WEIGHT="64.01681992322543" Z="0.4302414210985262">
<NAME>Salpingostomy or Salpingo-ovariolysis</NAME>
<DICH_DATA CI_END="3.0621077663069443" CI_START="0.48859465030292254" EFFECT_SIZE="1.2231637148266803" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.4860204709765017" LOG_CI_START="-0.31105129249283153" LOG_EFFECT_SIZE="0.08748458924183507" MODIFIED="2008-08-13 02:40:32 +1200" MODIFIED_BY="James M N Duffy" ORDER="14094" O_E="0.9189189189189193" SE="0.4682038994307488" STUDY_ID="STD-Tulandi-1989" TOTAL_1="36" TOTAL_2="38" VAR="4.561733892352183" WEIGHT="64.01681992322543"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.302503745920113" CI_START="0.19909023475748486" DF="0.0" EFFECT_SIZE="0.6770568744981647" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="0.36220034541877205" LOG_CI_START="-0.7009500413033085" LOG_EFFECT_SIZE="-0.16937484794226823" MODIFIED="2008-08-19 10:43:49 +1200" MODIFIED_BY="jane clarke" NO="2" P_CHI2="1.0" P_Z="0.5322994052951229" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="35.98318007677458" Z="0.6244997998398398">
<NAME>Laparoscopic ovarian drilling</NAME>
<DICH_DATA CI_END="2.302503745920113" CI_START="0.19909023475748486" EFFECT_SIZE="0.6770568744981647" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.36220034541877205" LOG_CI_START="-0.7009500413033085" LOG_EFFECT_SIZE="-0.16937484794226823" ORDER="14096" O_E="-1.0" SE="0.6244997998398398" STUDY_ID="STD-Gurgan-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.564102564102564" WEIGHT="35.98318007677458"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3232959030719864" CI_START="0.19099904988182237" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6661436107034877" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.3661045265834092" LOG_CI_START="-0.7189687931298013" LOG_EFFECT_SIZE="-0.1764321332731961" METHOD="PETO" MODIFIED="2008-08-19 10:49:35 +1200" MODIFIED_BY="jane clarke" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.5238790239619213" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0" Z="0.6373774391990982">
<NAME>Livebirth rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3232959030719864" CI_START="0.19099904988182237" DF="0.0" EFFECT_SIZE="0.6661436107034877" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="0.3661045265834092" LOG_CI_START="-0.7189687931298013" LOG_EFFECT_SIZE="-0.1764321332731961" MODIFIED="2008-08-19 10:49:35 +1200" MODIFIED_BY="jane clarke" NO="1" P_CHI2="1.0" P_Z="0.5238790239619213" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0" Z="0.6373774391990982">
<NAME>Laparoscopic ovarian drilling</NAME>
<DICH_DATA CI_END="2.3232959030719864" CI_START="0.19099904988182237" EFFECT_SIZE="0.6661436107034877" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3661045265834092" LOG_CI_START="-0.7189687931298013" LOG_EFFECT_SIZE="-0.1764321332731961" ORDER="14097" O_E="-1.0" SE="0.6373774391990981" STUDY_ID="STD-Gurgan-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.4615384615384617" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.805153070682237" CI_START="0.47601071812993373" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.5123836695427875" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="0.6817072269044151" LOG_CI_START="-0.32238326834614384" LOG_EFFECT_SIZE="0.17966197927913555" METHOD="PETO" MODIFIED="2008-08-19 10:44:02 +1200" MODIFIED_BY="jane clarke" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.48305781111851176" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="58" WEIGHT="100.0" Z="0.7013929729320207">
<NAME>Ectopic pregnancy rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.805153070682237" CI_START="0.47601071812993373" DF="0.0" EFFECT_SIZE="1.5123836695427875" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="0.0" ID="CMP-006.03.01" LOG_CI_END="0.6817072269044151" LOG_CI_START="-0.32238326834614384" LOG_EFFECT_SIZE="0.17966197927913555" MODIFIED="2008-08-13 02:42:19 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="1.0" P_Z="0.48305781111851176" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="38" WEIGHT="100.0" Z="0.7013929729320207">
<NAME>Salpingostomy or Salpingo-ovariolysis</NAME>
<DICH_DATA CI_END="4.805153070682237" CI_START="0.47601071812993373" EFFECT_SIZE="1.5123836695427875" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.6817072269044151" LOG_CI_START="-0.32238326834614384" LOG_EFFECT_SIZE="0.17966197927913555" MODIFIED="2008-08-13 02:42:19 +1200" MODIFIED_BY="James M N Duffy" ORDER="14098" O_E="1.1891891891891895" SE="0.5898077272382901" STUDY_ID="STD-Tulandi-1989" TOTAL_1="36" TOTAL_2="38" VAR="2.874611004933108" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-19 10:44:02 +1200" MODIFIED_BY="jane clarke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Laparoscopic ovarian drilling</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14100" O_E="0.0" SE="0.0" STUDY_ID="STD-Gurgan-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="10.87514704330708" CI_START="0.14857251576065728" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.2711207478014066" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="1.036435137779791" LOG_CI_START="-0.8280615227252006" LOG_EFFECT_SIZE="0.10418680752729524" METHOD="PETO" MODIFIED="2008-11-12 08:59:16 +1300" MODIFIED_BY="jane clarke" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.8266166193412186" Q="0.0" RANDOM="NO" SCALE="13.31648448412169" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="9" TOTAL_2="11" WEIGHT="100.0" Z="0.21904291355759026">
<NAME>Miscarriage rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.87514704330708" CI_START="0.14857251576065728" DF="0.0" EFFECT_SIZE="1.2711207478014066" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-006.04.01" LOG_CI_END="1.036435137779791" LOG_CI_START="-0.8280615227252006" LOG_EFFECT_SIZE="0.10418680752729524" MODIFIED="2008-08-19 10:49:05 +1200" MODIFIED_BY="jane clarke" NO="1" P_CHI2="1.0" P_Z="0.8266166193412186" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="11" WEIGHT="100.0" Z="0.21904291355759026">
<NAME>Laparoscopic ovarian drilling</NAME>
<DICH_DATA CI_END="10.87514704330708" CI_START="0.14857251576065728" EFFECT_SIZE="1.2711207478014066" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="1.036435137779791" LOG_CI_START="-0.8280615227252006" LOG_EFFECT_SIZE="0.10418680752729524" ORDER="14101" O_E="0.19999999999999996" SE="1.0952145677879515" STUDY_ID="STD-Gurgan-1992" TOTAL_1="9" TOTAL_2="11" VAR="0.8336842105263158" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-19 10:43:36 +1200" MODIFIED_BY="jane clarke" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="37" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Infection rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-13 02:42:48 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Salpingostomy or Salpingo-ovariolysis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14102" O_E="0.0" SE="0.0" STUDY_ID="STD-Tulandi-1989" TOTAL_1="17" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-19 10:43:36 +1200" MODIFIED_BY="jane clarke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Laparoscopic ovarian drilling</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14104" O_E="0.0" SE="0.0" STUDY_ID="STD-Gurgan-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-19 10:44:18 +1200" MODIFIED_BY="jane clarke" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="37" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Complication rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-13 02:43:03 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Salpingostomy or Salpingo-ovariolysis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14105" O_E="0.0" SE="0.0" STUDY_ID="STD-Tulandi-1989" TOTAL_1="17" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-19 10:44:18 +1200" MODIFIED_BY="jane clarke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Laparoscopic ovarian drilling</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14107" O_E="0.0" SE="0.0" STUDY_ID="STD-Gurgan-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="17" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-006.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-19 10:44:54 +1200" MODIFIED_BY="jane clarke" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Tubal patency rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Decreased odds</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Increased odds</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="17" EVENTS_2="19" I2="0.0" ID="CMP-006.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-13 02:43:16 +1200" MODIFIED_BY="James M N Duffy" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Salpingostomy or Salpingo-ovariolysis</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="17" EVENTS_2="19" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="14108" O_E="0.0" SE="0.0" STUDY_ID="STD-Tulandi-1989" TOTAL_1="17" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-10-29 11:19:08 +1300" MODIFIED_BY="jane clarke">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-10-29 11:19:00 +1300" MODIFIED_BY="jane clarke" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAfMAAADnCAMAAAA94U9AAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-10-29 11:19:08 +1300" MODIFIED_BY="jane clarke" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASYAAAGACAIAAACP41h+AAAQKElEQVR42u3dv45cVRLH8ZFICBw4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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-10-29 11:30:22 +1300" MODIFIED_BY="jane clarke">
<APPENDIX ID="APP-01" MODIFIED="2008-08-19 11:00:50 +1200" MODIFIED_BY="jane clarke" NO="1">
<TITLE MODIFIED="2008-08-13 01:23:07 +1200" MODIFIED_BY="James M N Duffy">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-19 11:00:50 +1200" MODIFIED_BY="jane clarke">
<P>1 gynecologic surgical procedures/ or hysteroscopy/ or salpingostomy/ or sterilization, tubal/ (8462)<BR/>2 exp adnexal diseases/su or endometriosis/su or exp uterine diseases/su (28082)<BR/>3 Polycystic Ovary Syndrome/su (429)<BR/>4 Pelvic Inflammatory Disease/su or exp Pelvic Pain/su or Pelvis/su (1517)<BR/>5 Sterilization Reversal/ (918)<BR/>6 ((tubal or pelvic or ovar$ or uter$ or fertility or reproducti$) adj surgery).tw. (1802)<BR/>7 (tubal adj disease).tw. (297)<BR/>8 (block$ adj5 tub$).tw. (1817)<BR/>9 (salpingo-ovariolysis or salpingostomy or tubal reanastomosis or cornual anastomosis or utero tubal implantation).tw. (380)<BR/>10 or/1-9 (39707)<BR/>11 second-look surgery/ (173)<BR/>12 Hysterosalpingography/ (3309)<BR/>13 Fallopian Tube Patency Tests/ (527)<BR/>14 (hydrotubation or hysterosalpingogr$ or salpingog$ or HSG).tw. (2403)<BR/>15 (postoperative laparoscop$ or postoperative procedure$ or second-look laparoscop$).tw. (364)<BR/>16 adhesiolysis.tw. (485)<BR/>17 tub$ patency.tw. (616)<BR/>18 or/11-17 (5749)<BR/>19 10 and 18 (1108)<BR/>20 randomised controlled trial.pt. (229481)<BR/>21 controlled clinical trial.pt. (74116)<BR/>22 Randomized Controlled Trials/ (46944)<BR/>23 Random allocation/ (56812)<BR/>24 Double-blind method/ (89516)<BR/>25 Single-blind method/ (10609)<BR/>26 or/20-25 (389441)<BR/>27 clinical trial.pt. (431918)<BR/>28 exp clinical trials/ (186631)<BR/>29 (clin$ adj25 trial$).ti,ab,sh. (125917)<BR/>30 ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$)).ti,ab,sh. (88774)<BR/>31 Placebos/ (25762)<BR/>32 placebo$.ti,ab,sh. (112355)<BR/>33 random$.ti,ab,sh. (478353)<BR/>34 Research design/ (46062)<BR/>35 or/27-34 (847992)<BR/>36 animal/ not (human/ and animal/) (3032479)<BR/>37 26 or 35 (854870)<BR/>38 37 not 36 (783796)<BR/>39 19 and 38 (160)<BR/>40 exp Carcinoma/ (352410)<BR/>41 (cancer$ or carcinoma).tw. (756335)<BR/>42 39 not (40 or 41) (135)<BR/>43 Male/ (4658956)<BR/>44 42 not 43 (132)<BR/>45 from 44 keep 1-132 (132)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-10-29 11:30:19 +1300" MODIFIED_BY="jane clarke" NO="2">
<TITLE MODIFIED="2008-10-29 11:21:19 +1300" MODIFIED_BY="jane clarke">CENTRAL</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-29 11:30:19 +1300" MODIFIED_BY="jane clarke">
<P>1 second-look surgery/ (16)<BR/>2 Hysterosalpingography/ (77)<BR/>3 Fallopian Tube Patency Tests/ (22)<BR/>4 (hydrotubation or hysterosalpingogr$ or salpingog$ or HSG).tw. (116)<BR/>5 (postoperative laparoscop$ or postoperative procedure$ or second-look laparoscop$).tw. (83)<BR/>6 adhesiolysis.tw. (34)<BR/>7 tub$ patency.tw. (49)<BR/>8 or/1-7 (267)<BR/>9 exp gynecologic surgery/ or exp uterine tube surgery/ or exp uterus surgery/ or exp sterilization reversal/ (1988)<BR/>10 exp adnexa disease/ or exp ovary disease/ or exp ovary cyst/ or exp follicle cyst/ or exp ovary polycystic disease/ or exp stein leventhal syndrome/ or exp ovary insufficiency/ or exp ovary tumor/ or exp pelvic inflammatory disease/ (445)<BR/>11 ((tubal or pelvic or ovar$ or uter$ or fertility or reproducti$) adj surgery).tw. (92)<BR/>12 (tubal adj disease).tw. (18)<BR/>13 (block$ adj5 tub$).tw. (117)<BR/>14 (salpingo-ovariolysis or salpingostomy or tubal reanastomosis or cornual anastomosis or utero tubal implantation).tw. (28)<BR/>15 or/9-14 (2637)<BR/>16 8 and 15 (45)<BR/>17 limit 16 to yr="2002 - 2007" (12)<BR/>18 from 17 keep 1-12 (12)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2008-10-29 11:30:22 +1300" MODIFIED_BY="jane clarke" NO="3">
<TITLE MODIFIED="2008-10-29 11:21:49 +1300" MODIFIED_BY="jane clarke">EMBASE</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-29 11:30:22 +1300" MODIFIED_BY="jane clarke">
<P>1 second-look surgery/ (1449)<BR/>2 Hysterosalpingography/ (1529)<BR/>3 Fallopian Tube Patency Tests/ (1460)<BR/>4 (hydrotubation or hysterosalpingogr$ or salpingog$ or HSG).tw. (1645)<BR/>5 (postoperative laparoscop$ or postoperative procedure$ or second-look laparoscop$).tw. (349)<BR/>6 adhesiolysis.tw. (509)<BR/>7 tub$ patency.tw. (535)<BR/>8 or/1-7 (6000)<BR/>9 exp gynecologic surgery/ or exp uterine tube surgery/ or exp uterus surgery/ or exp sterilization reversal/ (55648)<BR/>10 exp adnexa disease/ or exp ovary disease/ or exp ovary cyst/ or exp follicle cyst/ or exp ovary polycystic disease/ or exp stein leventhal syndrome/ or exp ovary insufficiency/ or exp ovary tumor/ or exp pelvic inflammatory disease/ (65719)<BR/>11 ((tubal or pelvic or ovar$ or uter$ or fertility or reproducti$) adj surgery).tw. (1615)<BR/>12 (tubal adj disease).tw. (284)<BR/>13 (block$ adj5 tub$).tw. (1548)<BR/>14 (salpingo-ovariolysis or salpingostomy or tubal reanastomosis or cornual anastomosis or utero tubal implantation).tw. (347)<BR/>15 or/9-14 (116999)<BR/>16 8 and 15 (2302)<BR/>17 Controlled study/ or randomised controlled trial/ (2470434)<BR/>18 double blind procedure/ (64962)<BR/>19 single blind procedure/ (6784)<BR/>20 crossover procedure/ (18946)<BR/>21 drug comparison/ (81250)<BR/>22 placebo/ (101777)<BR/>23 random$.ti,ab,hw,tn,mf. (376909)<BR/>24 latin square.ti,ab,hw,tn,mf. (1071)<BR/>25 crossover.ti,ab,hw,tn,mf. (33101)<BR/>26 cross-over.ti,ab,hw,tn,mf. (11407)<BR/>27 placebo$.ti,ab,hw,tn,mf. (150676)<BR/>28 ((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).ti,ab,hw,tn,mf. (108040)<BR/>29 (comparative adj5 trial$).ti,ab,hw,tn,mf. (6105)<BR/>30 (clinical adj5 trial$).ti,ab,hw,tn,mf. (496797)<BR/>31 or/17-30 (2960973)<BR/>32 nonhuman/ (2922616)<BR/>33 animal/ not (human/ and animal/) (12862)<BR/>34 or/32-33 (2926220)<BR/>35 31 not 34 (1741888)<BR/>36 16 and 35 (655)<BR/>37 (2002$ or 2003$ or 2004$ or 2005$ or 2006$ or 2007$).em. (3072997)<BR/>38 36 and 37 (294)<BR/>39 from 38 keep 1-294 (294)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>